<SEC-DOCUMENT>0001140361-25-038552.txt : 20251020
<SEC-HEADER>0001140361-25-038552.hdr.sgml : 20251020
<ACCEPTANCE-DATETIME>20251020060218
ACCESSION NUMBER:		0001140361-25-038552
CONFORMED SUBMISSION TYPE:	424B2
PUBLIC DOCUMENT COUNT:		15
FILED AS OF DATE:		20251020
DATE AS OF CHANGE:		20251020

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			TORONTO DOMINION BANK
		CENTRAL INDEX KEY:			0000947263
		STANDARD INDUSTRIAL CLASSIFICATION:	COMMERCIAL BANKS, NEC [6029]
		ORGANIZATION NAME:           	02 Finance
		EIN:				135640479
		STATE OF INCORPORATION:			A6
		FISCAL YEAR END:			1031

	FILING VALUES:
		FORM TYPE:		424B2
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-283969
		FILM NUMBER:		251402227

	BUSINESS ADDRESS:	
		STREET 1:		66 WELLINGTON STREET WEST
		STREET 2:		12TH FLOOR, TD TOWER
		CITY:			TORONTO, ONTARIO
		STATE:			A6
		ZIP:			M5K 1A2
		BUSINESS PHONE:		416-944-6367

	MAIL ADDRESS:	
		STREET 1:		66 WELLINGTON STREET WEST
		STREET 2:		12TH FLOOR, TD TOWER
		CITY:			TORONTO, ONTARIO
		STATE:			A6
		ZIP:			M5K 1A2
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B2
<SEQUENCE>1
<FILENAME>ef20057361_424b2.htm
<DESCRIPTION>PRICING SUPPLEMENT
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge
         Document created using Broadridge PROfile 25.10.1.5333
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: Arial; font-size: 9pt; text-align: left; color: #000000;">
  <div style="width: 100%;" class="BRPFPageHeader"></div>
  <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
  <div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zcd46e2347db64ce9a70b7f25580c0f51">

        <tr>
          <td style="width: 10%; vertical-align: top;">
            <div style="text-align: justify;"><img width="57" height="47" src="image0.jpg"></div>
          </td>
          <td style="width: 90%; vertical-align: top;">
            <div style="text-align: right; font-size: 8pt; font-weight: bold;">Filed Pursuant to Rule 424(b)(2)</div>
            <div style="text-align: right; font-size: 8pt; font-weight: bold;">Registration Statement No. 333-283969</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

        <tr>
          <td style="vertical-align: top; background-color: rgb(0, 0, 0); width: 100%;">&#160;</td>
        </tr>

    </table>
    <div style="text-align: justify; font-size: 8.5pt;">Pricing Supplement dated October 16, 2025 to the</div>
    <div style="text-align: justify; font-size: 8.5pt;">Product Supplement MLN-EI-1 dated February 26, 2025,</div>
    <div style="text-align: justify; font-size: 8.5pt;">Underlier Supplement dated February 26, 2025 and</div>
    <div style="text-align: justify; font-size: 8.5pt;">Prospectus dated February 26, 2025</div>
    <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z49b658e305ee40c8872d54855822a76a">

        <tr>
          <td nowrap="nowrap" style="border-width: 4px; border-style: solid; border-color: rgb(0, 176, 80); vertical-align: bottom; width: 100%; text-align: center;">
            <div style="color: rgb(0, 176, 80); font-size: 16pt;">The Toronto-Dominion Bank</div>
            <div style="font-size: 10pt;">$1,091,000</div>
            <div style="font-size: 10pt;">Callable Contingent Interest Barrier Notes Linked to the Least Performing of the Nasdaq-100 Index<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup>, the Russell </div>
            <div style="font-size: 10pt;">2000<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index and the S&amp;P 500<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index<font style="font-size: 8pt;">&#160;</font>Due October 21, 2030</div>
          </td>
        </tr>

    </table>
    <div style="text-align: justify; margin-top: 6pt; font-size: 7pt;">The Toronto-Dominion Bank (&#8220;TD&#8221; or &#8220;we&#8221;) has offered the Callable Contingent Interest Barrier Notes (the &#8220;Notes&#8221;) linked to the least performing of the Nasdaq-100 Index<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup>, the
      Russell 2000<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index and the S&amp;P 500<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index (each, a &#8220;Reference Asset&#8221; and together, the &#8220;Reference Assets&#8221;).</div>
    <div style="text-align: justify; margin-top: 6pt; margin-bottom: 3pt; font-size: 7pt;">The Notes will pay a Contingent Interest Payment on a Contingent Interest Payment Date (including the Maturity Date) at a per annum rate of approximately 6.95% (the
      &#8220;Contingent Interest Rate&#8221;) only if, on the related Contingent Interest Observation Date, the Closing Value of each Reference Asset is greater than or equal to its Contingent Interest Barrier Value, which is equal to 75.00% of its Initial Value. If,
      however, the Closing Value of any Reference Asset is less than its Contingent Interest Barrier Value on a Contingent Interest Observation Date, no Contingent Interest Payment will accrue or be payable on the related Contingent Interest Payment Date.</div>
    <div style="text-align: justify; margin-top: 6pt; margin-bottom: 3pt; font-size: 7pt;">TD may, in its discretion, elect to call the Notes (an &#8220;Issuer Call&#8221;) in whole, but not in part, on any Call Payment Date (monthly, commencing on the twelfth
      Contingent Interest Payment Date and other than the Maturity Date) upon at least three Business Days&#8217; prior written notice, regardless of the Closing Values of the Reference Assets. If TD elects to call the Notes prior to maturity, the Call Payment
      Date will be the corresponding Contingent Interest Payment Date and, on such date, we will pay you a cash payment per Note equal to the Principal Amount, plus any Contingent Interest Payment otherwise due. No further amounts will be owed under the
      Notes following an Issuer Call.</div>
    <div style="text-align: justify; margin-top: 6pt; margin-bottom: 3pt; font-size: 7pt;">If TD does not elect to call the Notes prior to maturity, the amount we pay at maturity, in addition to any Contingent Interest Payment otherwise due, if anything,
      will depend on the Closing Value of each Reference Asset on its Final Valuation Date (each, its &#8220;Final Value&#8221;) relative to its Barrier Value, which is equal to 60.00% of its Initial Value, calculated as follows:</div>
    <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-bottom: 3pt;" class="DSPFListTable" id="z3de5a30fb4e24044a300c0f0c9cd2b7e">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; font-size: 7pt;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-size: 7pt;">If the Final Value of each Reference Asset is greater than or equal to its Barrier Value:</div>
          </td>
        </tr>

    </table>
    <div style="text-align: justify; text-indent: 72pt; margin-left: 36pt; margin-bottom: 3pt; font-size: 7pt;">the Principal Amount of $1,000</div>
    <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-bottom: 3pt;" class="DSPFListTable" id="z6d40297a162e42eba6995213938c6db8">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; font-size: 7pt;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-size: 7pt;">If the Final Value of any Reference Asset is less than its Barrier Value:</div>
          </td>
        </tr>

    </table>
    <div style="text-align: justify; text-indent: 72pt; margin-left: 36pt; margin-bottom: 3pt; font-size: 7pt;">the sum of (1) $1,000 plus (2) the product of (i) $1,000 times (ii) the Least Performing Percentage Change</div>
    <div style="text-align: justify; margin-bottom: 3pt; font-size: 7pt;"><font style="font-weight: bold; font-style: italic;">If TD does not elect to call the Notes prior to maturity and the Final Value of any Reference Asset is less than its Barrier
        Value, investors will suffer a percentage loss on their initial investment that is equal to the percentage decline of the Reference Asset with the lowest Percentage Change from its Initial Value to its Final Value (the &#8220;Least Performing Reference
        Asset&#8221;). Specifically, investors will lose 1% of the Principal Amount of the Notes for each 1% that the Final Value of the Least Performing Reference Asset is less than its Initial Value, and may lose the entire Principal Amount.</font>&#160;<font style="font-weight: bold; font-style: italic;">Any payments on the Notes are subject to our credit risk.</font></div>
    <div>
      <div>
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;" id="z2226f2848c4d4ec1b69620b9d65f60a1">

            <tr>
              <td style="border-bottom: 1px solid rgb(0, 0, 0); border-left: 1px solid; border-top: 1px solid rgb(0, 0, 0); width: 1%;">
                <div>&#160;</div>
              </td>
              <td style="border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid rgb(0, 0, 0); width: 98%;">
                <div style="font-size: 7pt; font-weight: bold; text-align: justify;">The Notes do not guarantee the payment of any Contingent Interest Payments or the return of the Principal Amount. Investors are exposed to the market risk of each
                  Reference Asset on each Contingent Interest Observation Date (including the Final Valuation Date) and any decline in the value of one Reference Asset will not be offset or mitigated by a lesser decline or potential increase in the value
                  of any other Reference Asset. If the Final Value of any Reference Asset is less than its Barrier Value, investors may lose up to their entire investment in the Notes. Any payments on the Notes are subject to our credit risk.</div>
              </td>
              <td style="border-bottom: 1px solid #000000; border-right: 1px solid; border-top: 1px solid #000000; width: 1%;">
                <div>&#160;</div>
              </td>
            </tr>

        </table>
      </div>
    </div>
    <div style="margin: 2pt 0px; font-size: 7pt; text-align: justify;">The Notes are unsecured and are not savings accounts or insured deposits of a bank. The Notes are not insured or guaranteed by the Canada Deposit Insurance Corporation, the U.S. Federal
      Deposit Insurance Corporation or any other governmental agency or instrumentality of Canada or the United States. The Notes will not be listed or displayed on any securities exchange or electronic communications network.</div>
    <div style="text-align: justify; margin-bottom: 2pt; font-size: 7pt;"><font style="font-weight: bold;">The Notes have complex features and investing in the Notes involves a number of risks. See &#8220;Additional Risk Factors&#8221; beginning on page P-7 of this
        pricing supplement, &#8220;Additional Risk Factors Specific to the Notes&#8221; beginning on page PS-7 of the product supplement MLN-EI-1 dated February 26, 2025 (the &#8220;product supplement&#8221;)</font>&#160;<font style="font-weight: bold;">and &#8220;Risk Factors&#8221; on page 1 of
        the prospectus dated February 26, 2025 (the &#8220;prospectus&#8221;).</font></div>
    <div style="text-align: justify; margin-bottom: 2pt; font-size: 7pt; font-weight: bold;">Neither the Securities and Exchange Commission (the &#8220;SEC&#8221;) nor any state securities commission has approved or disapproved of these Notes or determined that this
      pricing supplement, the product supplement, the underlier supplement or the prospectus is truthful or complete. Any representation to the contrary is a criminal offense.</div>
    <div style="text-align: justify; margin-bottom: 2pt; font-size: 7pt;">We will deliver the Notes in book-entry only form through the facilities of The Depository Trust Company on the Issue Date against payment in immediately available funds.</div>
    <div style="text-align: justify; margin-bottom: 2pt; font-size: 7pt;">The estimated value of your Notes at the time the terms of your Notes were set on the Pricing Date was $926.70 per Note, as discussed further under &#8220;Additional Risk Factors &#8212; Risks
      Relating to Estimated Value and Liquidity&#8221; beginning on page P-10 and &#8220;Additional Information Regarding the Estimated Value of the Notes&#8221; on page P-23 of this pricing supplement. The estimated value is less than the public offering price of the
      Notes.</div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zb5775bd0e9824dd8a5d56b80d61ebbac">

        <tr>
          <td style="width: 17.87%; vertical-align: top; border-bottom: #D9D9D9 1px solid;">&#160;</td>
          <td style="width: 25.96%; vertical-align: top; border-bottom: #D9D9D9 1px solid;">
            <div style="text-align: justify; margin-bottom: 3pt; font-size: 7pt; font-weight: bold;">Public Offering Price</div>
          </td>
          <td style="width: 25.96%; vertical-align: top; border-bottom: #D9D9D9 1px solid;">
            <div style="text-align: justify; margin-bottom: 3pt; font-size: 7pt; font-weight: bold;">Underwriting Discount<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">1</sup></div>
          </td>
          <td style="width: 30.2%; vertical-align: top; border-bottom: #D9D9D9 1px solid;">
            <div style="text-align: justify; margin-bottom: 3pt; font-size: 7pt; font-weight: bold;">Proceeds to TD<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">1</sup></div>
          </td>
        </tr>
        <tr>
          <td style="width: 17.87%; vertical-align: top; border-top: #D9D9D9 1px solid; border-bottom: #D9D9D9 1px solid;">
            <div style="text-align: justify; margin-bottom: 3pt; font-size: 7pt;">Per Note</div>
          </td>
          <td style="width: 25.96%; vertical-align: top; border-top: #D9D9D9 1px solid; border-bottom: #D9D9D9 1px solid;">
            <div style="margin-bottom: 3pt; font-size: 7pt;">$1,000.00</div>
          </td>
          <td style="width: 25.96%; vertical-align: top; border-top: #D9D9D9 1px solid; border-bottom: #D9D9D9 1px solid;">
            <div style="margin-bottom: 3pt; font-size: 7.5pt;">$36.25</div>
          </td>
          <td style="width: 30.2%; vertical-align: top; border-top: #D9D9D9 1px solid; border-bottom: #D9D9D9 1px solid;">
            <div style="margin-bottom: 3pt; font-size: 7.5pt;">$963.75</div>
          </td>
        </tr>
        <tr>
          <td style="width: 17.87%; vertical-align: top; border-top: #D9D9D9 1px solid; border-bottom: #D9D9D9 1px solid;">
            <div style="text-align: justify; margin-bottom: 3pt; font-size: 7pt;">Total</div>
          </td>
          <td style="width: 25.96%; vertical-align: top; border-top: #D9D9D9 1px solid; border-bottom: #D9D9D9 1px solid;">
            <div style="margin-bottom: 3pt; font-size: 7pt;">$1,091,000.00</div>
          </td>
          <td style="width: 25.96%; vertical-align: top; border-top: #D9D9D9 1px solid; border-bottom: #D9D9D9 1px solid;">
            <div style="margin-bottom: 3pt; font-size: 7.5pt;">$39,548.75</div>
          </td>
          <td style="width: 30.2%; vertical-align: top; border-top: #D9D9D9 1px solid; border-bottom: #D9D9D9 1px solid;">
            <div style="margin-bottom: 3pt; font-size: 7.5pt;">$1,051,451.25</div>
          </td>
        </tr>

    </table>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%;" id="z12c2a82a2e844881be0253010a14aa7a" class="DSPFListTable">

          <tr style="vertical-align: top;">
            <td style="text-align: right; vertical-align: top; width: 9pt;">
              <div style="text-align: justify; margin-bottom: 3pt; font-size: 7pt;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">1</sup></div>
            </td>
            <td style="text-align: left; vertical-align: top; width: auto;">
              <div style="text-align: justify; margin-bottom: 3pt; font-size: 7pt;">TD Securities (USA) LLC (&#8220;TDS&#8221;) will receive a commission of $36.25 (3.625%) per Note and will use all of that commission to allow selling concessions to other dealers in
                connection with the distribution of the Notes. Such other dealers may resell the Notes to other securities dealers at the Principal Amount less a concession not in excess of $36.25 per Note. TD will also periodically pay one or more
                unaffiliated dealers a structuring fee and/or marketing fee of $5.00 per Note with respect to all of the Notes. TD will reimburse TDS for certain expenses in connection with its role in the offer and sale of the Notes, and TD will pay TDS a
                fee in connection with its role in the offer and sale of the Notes. See &#8220;Supplemental Plan of Distribution (Conflicts of Interest)&#8221; herein.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="font-size: 7pt; text-align: justify;">The public offering price, underwriting discount and proceeds to TD listed above relate to the Notes we issue initially. We may decide to sell additional Notes after the date of this pricing supplement,
      at public offering prices and with underwriting discounts and proceeds to TD that differ from the amounts set forth above. The return (whether positive or negative) on your investment in the Notes will depend in part on the public offering price you
      pay for such Notes.</div>
    <div><br>
    </div>
    <div> </div>
    <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
      <div style="width: 100%;" class="BRPFPageFooter">
        <div>
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;">

              <tr>
                <td style="width: 50.00%;">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-size: 8pt;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50.00%;">
                  <div style="text-align: right; color: rgb(0, 0, 0); font-size: 8pt;">P-<font class="BRPFPageNumber">1</font></div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div style="width: 100%;" class="BRPFPageHeader"></div>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" style="border-collapse: collapse; margin: 0px 0px 0px; width: 100%; color: #000000; font-family: Arial; font-size: 9pt; text-align: left;" id="z831cf0d5b4b54992bd9022f0e896c387">

        <tr>
          <td style="width: 44.64%; vertical-align: middle;">&#160;</td>
          <td style="width: 55.36%; vertical-align: middle;">
            <div style="text-align: right; font-size: 8pt;"><font style="font-weight: bold;">Callable Contingent Interest Barrier Notes Linked to the Least Performing of<br>
                &#160;the Nasdaq-100 Index</font><sup style="font-weight: bold; vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup><font style="font-weight: bold;">, the Russell 2000</font><sup style="font-weight: bold; vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup><font style="font-weight: bold;"> Index and the S&amp;P 500</font><sup style="font-weight: bold; vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup><font style="font-weight: bold;"> Index</font></div>
            <div style="margin: 0px 0px 8pt; font-size: 8pt; font-weight: bold; text-align: right;">Due October 21, 2030</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="4" border="0" style="border-collapse: collapse; margin: 0px 0px 9pt; width: 100%; color: #000000; font-family: Arial; font-size: 9pt; text-align: left;">

        <tr>
          <td style="width: 100%; vertical-align: middle; background-color: rgb(0, 0, 0);" rowspan="1"><br>
          </td>
        </tr>

    </table>
    <div style="text-align: justify; margin-top: 6pt; margin-bottom: 6pt; color: rgb(0, 176, 80); font-size: 16pt;">Summary</div>
    <div style="text-align: justify; margin-bottom: 6pt;">The information in this &#8220;Summary&#8221; section is qualified by the more detailed information set forth in this pricing supplement, the product supplement, the underlier supplement and the prospectus.</div>
    <table cellspacing="0" cellpadding="4" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z6a859213166144abae6614c064f2e2e1">

        <tr>
          <td style="width: 22%; vertical-align: top; border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Issuer:</div>
          </td>
          <td style="width: 78%; vertical-align: top; border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify; margin-bottom: 3pt;">TD</div>
          </td>
        </tr>
        <tr>
          <td style="width: 22%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Issue:</div>
          </td>
          <td style="width: 78%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify; margin-bottom: 3pt;">Senior Debt Securities, Series H</div>
          </td>
        </tr>
        <tr>
          <td style="width: 22%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Type of Note:</div>
          </td>
          <td style="width: 78%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify; margin-bottom: 3pt;">Callable Contingent Interest Barrier Notes</div>
          </td>
        </tr>
        <tr>
          <td style="width: 22%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Term:</div>
          </td>
          <td style="width: 78%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify; margin-bottom: 3pt;">Approximately 5 years, subject to an Issuer Call</div>
          </td>
        </tr>
        <tr>
          <td style="width: 22%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Reference Assets:</div>
          </td>
          <td style="width: 78%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify;">The Nasdaq-100 Index<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> (Bloomberg ticker: NDX, &#8220;NDX&#8221;), the Russell 2000<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index (Bloomberg ticker: RTY, &#8220;RTY&#8221;) and the S&amp;P 500<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index (Bloomberg ticker: SPX, &#8220;SPX&#8221;)</div>
          </td>
        </tr>
        <tr>
          <td style="width: 22%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">CUSIP / ISIN:</div>
          </td>
          <td style="width: 78%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify; margin-bottom: 6pt;">89115HX69 / US89115HX692</div>
          </td>
        </tr>
        <tr>
          <td style="width: 22%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Agent:</div>
          </td>
          <td style="width: 78%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify; margin-bottom: 6pt;">TDS</div>
          </td>
        </tr>
        <tr>
          <td style="width: 22%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Currency:</div>
          </td>
          <td style="width: 78%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify; margin-bottom: 3pt;">U.S. Dollars</div>
          </td>
        </tr>
        <tr>
          <td style="width: 22%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Minimum Investment:</div>
          </td>
          <td style="width: 78%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify; margin-bottom: 3pt;">$1,000 and minimum denominations of $1,000 in excess thereof</div>
          </td>
        </tr>
        <tr>
          <td style="width: 22%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Principal Amount:</div>
          </td>
          <td style="width: 78%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify; margin-bottom: 3pt;">$1,000 per Note</div>
          </td>
        </tr>
        <tr>
          <td style="width: 22%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Pricing Date:</div>
          </td>
          <td style="width: 78%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify;">October 16, 2025</div>
          </td>
        </tr>
        <tr>
          <td style="width: 22%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Issue Date:</div>
          </td>
          <td style="width: 78%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify; margin-bottom: 3pt;">October 21, 2025, which is the third DTC settlement day following the Pricing Date. Under Rule 15c6-1 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), trades in the
              secondary market generally are required to settle in one DTC settlement day (&#8220;T+1&#8221;), unless the parties to a trade expressly agree otherwise. Accordingly, purchasers who wish to trade the Notes in the secondary market on any date prior to one
              DTC settlement day before delivery of the Notes will be required, by virtue of the fact that each Note initially will settle in three DTC settlement days (&#8220;T+3&#8221;), to specify alternative settlement arrangements to prevent a failed settlement
              of the secondary market trade.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 22%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Final Valuation Date:</div>
          </td>
          <td style="width: 78%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify; margin-bottom: 6pt;">The final Contingent Interest Observation Date, as specified below under &#8220;Contingent Interest Observation Dates&#8221;.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 22%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Maturity Date:</div>
          </td>
          <td style="width: 78%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify; margin-bottom: 6pt;">October 21, 2030, subject to postponement upon the occurrence of a market disruption event as described in the accompanying product supplement.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 22%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Issuer Call Feature:</div>
          </td>
          <td style="width: 78%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify; margin-bottom: 3pt;">Monthly, commencing on the twelfth Contingent Interest Payment Date, TD may, in its discretion, elect to call the Notes in whole, but not in part, on any Call Payment Date (other than the
              Maturity Date) upon at least three Business Days&#8217; prior written notice, regardless of the Closing Values of the Reference Assets. If TD elects to call the Notes prior to maturity, on the related Call Payment Date, we will pay you a cash
              payment per Note equal to the Principal Amount, plus any Contingent Interest Payment otherwise due. No further amounts will be owed to you under the Notes following an Issuer Call.</div>
          </td>
        </tr>

    </table>
    <div style="margin-bottom: 10pt;"><br>
    </div>
    <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
      <div style="width: 100%;" class="BRPFPageFooter">
        <div>
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;">

              <tr>
                <td style="width: 50.00%;">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-size: 8pt;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50.00%;">
                  <div style="text-align: right; color: rgb(0, 0, 0); font-size: 8pt;">P-<font class="BRPFPageNumber">2</font></div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div style="width: 100%;" class="BRPFPageHeader"></div>
    </div>
    <table cellspacing="0" cellpadding="4" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zc8790fe31e324b738df99023b83c2305">

        <tr>
          <td style="width: 22%; vertical-align: top; border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Call Payment Date:</div>
          </td>
          <td style="width: 78%; vertical-align: top; border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify; margin-bottom: 3pt;">If TD elects to call the Notes prior to maturity (monthly, from and including the twelfth Contingent Interest Payment Date to and excluding the Maturity Date), the Call Payment Date will be
              the corresponding Contingent Interest Payment Date.</div>
          </td>
        </tr>
        <tr>
          <td nowrap="nowrap" style="width: 22%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Contingent Interest Payment:</div>
          </td>
          <td style="width: 78%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify; margin-bottom: 6pt;">If the Closing Value of each Reference Asset is greater than or equal to its Contingent Interest Barrier Value on any Contingent Interest Observation Date, a Contingent Interest Payment will
              be paid to you on the corresponding Contingent Interest Payment Date, in an amount equal to:</div>
            <div style="text-align: center; margin-bottom: 6pt;">Principal Amount &#215; Contingent Interest Rate &#215; <sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">1</sup>/<sub style="vertical-align: bottom; line-height: 1; font-size: smaller;">12</sub></div>
            <div style="text-align: justify; margin-bottom: 6pt;">If the Closing Value of any Reference Asset is less than its Contingent Interest Barrier Value on any Contingent Interest Observation Date, you will receive no Contingent Interest Payment on
              the corresponding Contingent Interest Payment Date.</div>
            <div style="text-align: justify; margin-bottom: 6pt;">All amounts used in or resulting from any calculation relating to a Contingent Interest Payment will be rounded upward or downward, as appropriate, to the nearest tenth of a cent.</div>
            <div style="text-align: justify; margin-bottom: 3pt; font-weight: bold;">Contingent Interest Payments on the Notes are not guaranteed. You will not receive a Contingent Interest Payment on a Contingent Interest Payment Date if the Closing Value
              of any Reference Asset on the related Contingent Interest Observation Date is less than its Contingent Interest Barrier Value.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 22%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Contingent Interest Rate:</div>
          </td>
          <td style="width: 78%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify; margin-bottom: 6pt;">Approximately 6.95% per annum</div>
          </td>
        </tr>
        <tr>
          <td style="width: 22%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="font-weight: bold;">Contingent Interest Barrier </div>
            <div style="margin-bottom: 6pt; font-weight: bold;">Value:</div>
          </td>
          <td style="width: 78%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="margin-bottom: 6pt;">With respect to NDX: 18,492.93<font style="font-size: 8pt;">&#160;</font>(75.00% of its Initial Value<font style="font-size: 8pt;">)</font>.</div>
            <div style="margin-bottom: 6pt;">With respect to RTY: 1,850.2613<font style="font-size: 8pt;">&#160;</font>(75.00% of its Initial Value<font style="font-size: 8pt;">)</font>.</div>
            <div style="margin-bottom: 6pt;">With respect to SPX: 4,971.8025<font style="font-size: 8pt;">&#160;</font>(75.00% of its Initial Value<font style="font-size: 8pt;">)</font>.</div>
            <div style="text-align: justify; margin-bottom: 6pt;">The Contingent Interest Barrier Value for each Reference Asset is determined by the Calculation Agent.</div>
          </td>
        </tr>
        <tr>
          <td nowrap="nowrap" style="width: 22%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="font-weight: bold;">Contingent Interest </div>
            <div style="margin-bottom: 6pt; font-weight: bold;">Observation Dates:</div>
          </td>
          <td style="width: 78%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify; margin-bottom: 3pt;">Monthly, on the 16th calendar day of each month, commencing on November 16, 2025 and ending on October 16, 2030 (the &#8220;Final Valuation Date&#8221;), subject to postponement upon the occurrence of a
              market disruption event as described in the accompanying product supplement.</div>
          </td>
        </tr>
        <tr>
          <td nowrap="nowrap" style="width: 22%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="font-weight: bold; text-align: justify;">Contingent Interest Payment </div>
            <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Dates:</div>
          </td>
          <td style="width: 78%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify; margin-bottom: 3pt;">With respect to each Contingent Interest Observation Date, the third Business Day following the relevant Contingent Interest Observation Date, with the exception of the final Contingent
              Interest Payment Date, which will be the Maturity Date, subject to postponement upon the occurrence of a market disruption event as described in the accompanying product supplement.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 22%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Payment at Maturity:</div>
            <div>&#160;</div>
          </td>
          <td style="width: 78%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify; margin-bottom: 6pt;">If TD does not elect to call the Notes prior to maturity, on the Maturity Date, in addition to any Contingent Interest Payment otherwise due, we will pay a cash payment, if anything,<font style="font-size: 8pt;">&#160;</font>per Note equal to:</div>
            <div style="text-align: justify; margin-bottom: 6pt;">If the Final Value of each Reference Asset is greater than or equal to its Barrier Value<font style="font-size: 8pt;">:</font></div>
            <div style="text-align: center; margin-bottom: 6pt;">Principal Amount of $1,000.</div>
            <div style="text-align: justify; margin-bottom: 6pt;">If the Final Value of any Reference Asset is less than its Barrier Value<font style="font-size: 8pt;">:</font></div>
            <div style="text-align: center; margin-bottom: 3pt;">$1,000 + ($1,000 &#215; Least Performing Percentage Change).</div>
            <div style="text-align: justify; margin-bottom: 6pt;"><font style="font-weight: bold; font-style: italic;">If TD does not elect to call the Notes prior to maturity and the Final Value of any Reference Asset is less than its Barrier Value,
                investors will suffer a percentage loss on their initial investment that is equal to the Least Performing Percentage Change. Specifically, investors will lose 1% of the Principal Amount of the Notes for each 1% that the Final Value of the
                Least Performing Reference Asset is less than its Initial Value, and may lose the entire Principal Amount.</font><font style="font-size: 8pt;">&#160;</font><font style="font-weight: bold; font-style: italic;">Any payments on the Notes are
                subject to our credit risk.</font></div>
            <div>All amounts used in or resulting from any calculation relating to the Payment at Maturity will be rounded upward or downward, as appropriate, to the nearest cent.</div>
          </td>
        </tr>

    </table>
    <div style="margin-bottom: 10pt;"><br>
    </div>
    <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
      <div style="width: 100%;" class="BRPFPageFooter">
        <div>
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;">

              <tr>
                <td style="width: 50.00%;">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-size: 8pt;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50.00%;">
                  <div style="text-align: right; color: rgb(0, 0, 0); font-size: 8pt;">P-<font class="BRPFPageNumber">3</font></div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div style="width: 100%;" class="BRPFPageHeader"></div>
    </div>
    <table cellspacing="0" cellpadding="4" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z81485039ad304576a7defd589b1ec564">

        <tr>
          <td style="width: 22%; vertical-align: top; border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Percentage Change:</div>
          </td>
          <td style="width: 78%; vertical-align: top; border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify; margin-bottom: 6pt;">For each Reference Asset, the Percentage Change is the quotient, expressed as a percentage, of the following formula:</div>
            <div style="text-align: center;"><u>Final Value &#8211; Initial Value</u></div>
            <div style="text-align: center; margin-bottom: 6pt;">Initial Value</div>
          </td>
        </tr>
        <tr>
          <td style="width: 22%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="margin-bottom: 6pt; font-weight: bold;">Initial Value:</div>
          </td>
          <td style="width: 78%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify; margin-bottom: 6pt;">With respect to NDX: 24,657.24</div>
            <div style="text-align: justify; margin-bottom: 6pt;">With respect to RTY: 2,467.015</div>
            <div style="text-align: justify; margin-bottom: 6pt;">With respect to SPX: 6,629.07</div>
            <div style="text-align: justify; margin-bottom: 6pt;">The Initial Value of each Reference Asset equals its Closing Value on the Pricing Date, as determined by the Calculation Agent.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 22%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="margin-bottom: 6pt; font-weight: bold;">Closing Value:</div>
          </td>
          <td style="width: 78%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify; margin-bottom: 3pt;">For each Reference Asset (or any "successor index" thereto, as defined in the product supplement) on any Trading Day, the Closing Value will be its closing value published by its sponsor
              (its "Index Sponsor") as displayed on the relevant Bloomberg Professional<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> service (&#8220;Bloomberg&#8221;) page or any successor page or service.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 22%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="margin-bottom: 6pt; font-weight: bold;">Final Value:</div>
          </td>
          <td style="width: 78%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify; margin-bottom: 3pt;">For each Reference Asset, the Closing Value of such Reference Asset on its Final Valuation Date.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 22%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="margin-bottom: 6pt; font-weight: bold;">Barrier Value:</div>
          </td>
          <td style="width: 78%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="margin-bottom: 6pt;">With respect to NDX: 14,794.344<font style="font-size: 8pt;">&#160;</font>(60.00% of its Initial Value).</div>
            <div style="margin-bottom: 6pt;">With respect to RTY: 1,480.209<font style="font-size: 8pt;">&#160;</font>(60.00% of its Initial Value).</div>
            <div style="margin-bottom: 6pt;">With respect to SPX: 3,977.442<font style="font-size: 8pt;">&#160;</font>(60.00% of its Initial Value).</div>
            <div style="text-align: justify; margin-bottom: 6pt;">The Barrier Value for each Reference Asset is determined by the Calculation Agent.</div>
          </td>
        </tr>
        <tr>
          <td nowrap="nowrap" style="width: 22%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="font-weight: bold;">Least Performing Reference </div>
            <div style="margin-bottom: 6pt; font-weight: bold;">Asset:</div>
          </td>
          <td style="width: 78%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify; margin-bottom: 3pt;">The Reference Asset with the lowest Percentage Change as compared to the Percentage Change of any other Reference Asset.</div>
          </td>
        </tr>
        <tr>
          <td nowrap="nowrap" style="width: 22%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="font-weight: bold;">Least Performing Percentage </div>
            <div style="margin-bottom: 6pt; font-weight: bold;">Change:</div>
          </td>
          <td style="width: 78%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify; margin-bottom: 3pt;">The Percentage Change of the Least Performing Reference Asset.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 22%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="margin-top: 3pt; margin-bottom: 3pt; font-weight: bold;">Monitoring Period:</div>
          </td>
          <td style="width: 78%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify; margin-bottom: 3pt;">Final Valuation Date Monitoring</div>
          </td>
        </tr>
        <tr>
          <td style="width: 22%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Trading Day:</div>
          </td>
          <td style="width: 78%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify; margin-bottom: 3pt;">A day on which the NYSE and the Nasdaq Stock Market, or their successors, are scheduled to be open for trading, as determined by the Calculation Agent.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 22%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Business Day:</div>
          </td>
          <td style="width: 78%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify; margin-bottom: 3pt;">Any day that is a Monday, Tuesday, Wednesday, Thursday or Friday that is neither a legal holiday nor a day on which banking institutions are authorized or required by law to close in New
              York City.</div>
          </td>
        </tr>

    </table>
    <div style="margin-bottom: 10pt;"><br>
    </div>
    <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
      <div style="width: 100%;" class="BRPFPageFooter">
        <div>
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;">

              <tr>
                <td style="width: 50.00%;">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-size: 8pt;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50.00%;">
                  <div style="text-align: right; color: rgb(0, 0, 0); font-size: 8pt;">P-<font class="BRPFPageNumber">4</font></div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div style="width: 100%;" class="BRPFPageHeader"></div>
    </div>
    <table cellspacing="0" cellpadding="4" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z71c27a973c31455bb189bd21a72f092e">

        <tr>
          <td style="width: 22%; vertical-align: top; border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">U.S. Tax Treatment:</div>
          </td>
          <td style="width: 78%; vertical-align: top; border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify; margin-bottom: 3pt;">By purchasing the Notes, you agree, in the absence of a statutory or regulatory change or an administrative determination or judicial ruling to the contrary, to treat the Notes, for U.S.
              federal income tax purposes, as prepaid derivative contracts with respect to the Reference Assets. Pursuant to this approach, it is likely that any Contingent Interest Payment that you receive should be included in ordinary income at the time
              you receive the payment or when it accrues, depending on your regular method of accounting for U.S. federal income tax purposes. Based on certain factual representations received from us, our special U.S. tax counsel, Fried, Frank, Harris,
              Shriver &amp; Jacobson LLP, is of the opinion that it would be reasonable to treat the Notes in the manner described above. However, because there is no authority that specifically addresses the tax treatment of the Notes, it is possible that
              your Notes could alternatively be treated for tax purposes as a single contingent payment debt instrument, or pursuant to some other characterization, such that the timing and character of your income from the Notes could differ materially
              and adversely from the treatment described above, as described further under &#8220;Material U.S. Federal Income Tax Consequences&#8221; herein and in the product supplement. <font style="font-weight: bold;">An investment in the Notes is not appropriate
                for non-U.S. holders and we will not attempt to ascertain the tax consequences to non-U.S. holders of the purchase, ownership or disposition of the Notes.</font></div>
          </td>
        </tr>
        <tr>
          <td style="width: 22%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Canadian Tax Treatment:</div>
          </td>
          <td style="width: 78%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify; margin-bottom: 3pt;">Please see the discussion in the prospectus under &#8220;Tax Consequences &#8212; Canadian Taxation&#8221; and in the product supplement under &#8220;Supplemental Discussion of Canadian Tax Consequences&#8221;, which
              applies to the Notes. We will not pay any additional amounts as a result of any withholding required by reason of the rules governing hybrid mismatch arrangements contained in section 18.4 of the Canadian Tax Act (as defined in the
              prospectus).</div>
          </td>
        </tr>
        <tr>
          <td style="width: 22%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Record Date:</div>
          </td>
          <td style="width: 78%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify; margin-bottom: 3pt;">The Business Day preceding the relevant Contingent Interest Payment Date.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 22%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Calculation Agent:</div>
          </td>
          <td style="width: 78%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify; margin-bottom: 3pt;">TD</div>
          </td>
        </tr>
        <tr>
          <td style="width: 22%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Listing:</div>
          </td>
          <td style="width: 78%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify; margin-bottom: 3pt;">The Notes will not be listed or displayed on any securities exchange or electronic communications network.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 22%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Canadian Bail-in:</div>
          </td>
          <td style="width: 78%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify; margin-bottom: 3pt;">The Notes are not bail-inable debt securities (as defined in the prospectus) under the Canada Deposit Insurance Corporation Act.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 22%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Change in Law Event:</div>
          </td>
          <td style="width: 78%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify; margin-bottom: 3pt;">Not applicable, notwithstanding anything to the contrary in the product supplement.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
      <div style="width: 100%;" class="BRPFPageFooter">
        <div>
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;">

              <tr>
                <td style="width: 50.00%;">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-size: 8pt;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50.00%;">
                  <div style="text-align: right; color: rgb(0, 0, 0); font-size: 8pt;">P-<font class="BRPFPageNumber">5</font></div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div style="width: 100%;" class="BRPFPageHeader"></div>
    </div>
    <div style="text-align: justify; margin-bottom: 12pt; color: rgb(0, 176, 80); font-size: 16pt;">Additional Terms of Your Notes</div>
    <div style="text-align: justify; margin-bottom: 6pt;">You should read this pricing supplement together with the prospectus, as supplemented by the product supplement MLN-EI-1 (the &#8220;product supplement&#8221;) and the underlier supplement (the &#8220;underlier
      supplement&#8221;), relating to our Senior Debt Securities, Series H, of which these Notes are a part. Capitalized terms used but not defined in this pricing supplement will have the meanings given to them in the product supplement. In the event of any
      conflict the following hierarchy will govern: first, this pricing supplement; second, the product supplement; third, the underlier supplement; and last, the prospectus. <font style="font-weight: bold; font-style: italic;">The Notes vary from the
        terms described in the product supplement in several important ways. You should read this pricing supplement carefully.</font></div>
    <div style="text-align: justify; margin-bottom: 6pt;">This pricing supplement, together with the documents listed below, contains the terms of the Notes and supersedes all prior or contemporaneous oral statements as well as any other written materials
      including preliminary or indicative pricing terms, correspondence, trade ideas, structures for implementation, sample structures, brochures or other educational materials of ours. You should carefully consider, among other things, the matters set
      forth in &#8220;Additional Risk Factors&#8221; herein, &#8220;Additional Risk Factors Specific to the Notes&#8221; in the product supplement and &#8220;Risk Factors&#8221; in the prospectus, as the Notes involve risks not associated with conventional debt securities. We urge you to
      consult your investment, legal, tax, accounting and other advisors concerning an investment in the Notes. You may access these documents on the SEC website at www.sec.gov as follows (or if that address has changed, by reviewing our filings for the
      relevant date on the SEC website):</div>
    <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-bottom: 6pt;" class="DSPFListTable" id="z9046d62f6c244733b978dc658a29fce2">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">&#9726;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Prospectus dated February 26, 2025:</div>
          </td>
        </tr>

    </table>
    <div style="text-align: justify; text-indent: 36pt; margin-bottom: 6pt;"><a href="https://www.sec.gov/Archives/edgar/data/947263/000119312525036639/d931193d424b5.htm">http://www.sec.gov/Archives/edgar/data/947263/000119312525036639/d931193d424b5.htm</a></div>
    <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-bottom: 6pt;" class="DSPFListTable" id="z18f8019574934ad7ab82b0a49d158cfd">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">&#9726;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Underlier Supplement dated February 26, 2025:</div>
          </td>
        </tr>

    </table>
    <div style="text-align: justify; text-indent: 36pt; margin-bottom: 6pt;"><a href="https://www.sec.gov/Archives/edgar/data/947263/000114036125006121/ef20044458_424b3.htm">http://www.sec.gov/Archives/edgar/data/947263/000114036125006121/ef20044458_424b3.htm</a></div>
    <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-bottom: 6pt;" class="DSPFListTable" id="z95ee621507df4eda8e7bf92272d7ff8a">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">&#9726;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Product Supplement MLN-EI-1 dated February 26, 2025:</div>
          </td>
        </tr>

    </table>
    <div style="text-align: justify; text-indent: 36pt; margin-bottom: 6pt;"><a href="https://www.sec.gov/Archives/edgar/data/947263/000114036125006123/ef20044459_424b3.htm">http://www.sec.gov/Archives/edgar/data/947263/000114036125006123/ef20044459_424b3.htm</a></div>
    <div style="text-align: justify; margin-bottom: 6pt;">Our Central Index Key, or CIK, on the SEC website is 0000947263. As used in this pricing supplement, the &#8220;Bank,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; or &#8220;our&#8221; refers to The Toronto-Dominion Bank and its subsidiaries.</div>
    <div style="text-align: justify;">We reserve the right to change the terms of, or reject any offer to purchase, the Notes prior to their issuance. In the event of any changes to the terms of the Notes, we will notify you and you will be asked to accept
      such changes in connection with your purchase. You may also choose to reject such changes, in which case we may reject your offer to purchase.</div>
    <div> <br>
    </div>
    <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
      <div style="width: 100%;" class="BRPFPageFooter">
        <div>
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;">

              <tr>
                <td style="width: 50.00%;">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-size: 8pt;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50.00%;">
                  <div style="text-align: right; color: rgb(0, 0, 0); font-size: 8pt;">P-<font class="BRPFPageNumber">6</font></div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div style="width: 100%;" class="BRPFPageHeader"></div>
    </div>
    <div style="text-align: justify; margin-bottom: 12pt; color: rgb(0, 176, 80); font-size: 16pt;">Additional Risk Factors</div>
    <div style="text-align: justify; margin-bottom: 6pt;">The Notes involve risks not associated with an investment in conventional debt securities. This section describes the most significant risks relating to the terms of the Notes. For additional
      information as to these and other risks, please see &#8220;Additional Risk Factors Specific to the Notes&#8221; in the product supplement and &#8220;Risk Factors&#8221; in the prospectus.</div>
    <div style="text-align: justify; margin-bottom: 6pt;">Investors should consult their investment, legal, tax, accounting and other advisors as to the risks entailed by an investment in the Notes and the suitability of the Notes in light of their
      particular circumstances.</div>
    <div style="text-align: center; margin-bottom: 6pt; font-style: italic; font-weight: bold;">Risks Relating to Return Characteristics</div>
    <div style="margin-bottom: 6pt; font-weight: bold;">Your Investment in the Notes May Result in a Loss.</div>
    <div style="text-align: justify; margin-bottom: 6pt;">The Notes do not guarantee the return of the Principal Amount and investors may lose up to their entire investment in the Notes. Specifically, if TD does not elect to call the Notes prior to
      maturity and the Final Value of any Reference Asset is less than its Barrier Value, investors will lose 1% of the Principal Amount of the Notes for each 1% that the Final Value of the Least Performing Reference Asset is less than its Initial Value,
      and may lose the entire Principal Amount.</div>
    <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">You Will Not Receive the Contingent Interest Payment With Respect to a Contingent Interest Observation Date if the Closing Value of Any Reference Asset on Such Contingent Interest
      Observation Date Is Less Than Its Contingent Interest Barrier Value.</div>
    <div style="text-align: justify; margin-bottom: 6pt;">You will not receive a Contingent Interest Payment on a Contingent Interest Payment Date if the Closing Value of any Reference Asset on the related Contingent Interest Observation Date is less than
      its Contingent Interest Barrier Value. If the Closing Value of any Reference Asset is less than its Contingent Interest Barrier Value on each Contingent Interest Observation Date over the term of the Notes, you will not receive any Contingent
      Interest Payments and, therefore, you will not receive a positive return on your Notes. Generally, this non-payment of any Contingent Interest Payment will coincide with a greater risk of principal loss on your Notes at maturity.</div>
    <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">The Potential Positive Return on the Notes Is Limited to the Contingent Interest Payments Paid on the Notes, if Any, Regardless of Any Appreciation of Any Reference Asset.</div>
    <div style="text-align: justify; margin-bottom: 6pt;">The potential positive return on the Notes is limited to any Contingent Interest Payments paid, meaning any positive return on the Notes will be composed solely of the sum of any Contingent Interest
      Payments paid over the term of the Notes. Therefore, if the appreciation of any Reference Asset exceeds the sum of any Contingent Interest Payments actually paid on the Notes, the return on the Notes will be less than the return on a hypothetical
      direct investment in such Reference Asset, in a security directly linked to the positive performance of such Reference Asset or a hypothetical investment in the stocks and other assets comprising such Reference Asset (its &#8220;Reference Asset
      Constituents&#8221;).</div>
    <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Your Return May Be Less Than the Return on a Conventional Debt Security of Comparable Maturity.</div>
    <div style="text-align: justify; margin-bottom: 6pt;">The return that you will receive on your Notes, which could be negative, may be less than the return you could earn on other investments. The Notes do not provide for fixed interest payments and you
      may not receive any Contingent Interest Payments over the term of the Notes. Even if you do receive one or more Contingent Interest Payments and your return on the Notes is positive, your return may be less than the return you would earn if you
      bought a conventional, interest-bearing senior debt security of TD of comparable maturity. Your investment may not reflect the full opportunity cost to you when you take into account factors that affect the time value of money.</div>
    <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">TD May Elect to Call the Notes Prior to the Maturity Date and the Notes Are Subject to Reinvestment Risk.</div>
    <div style="text-align: justify; margin-bottom: 6pt;">TD may elect to call the Notes in its discretion on any Call Payment Date (monthly, commencing on the twelfth Contingent Interest Payment Date and other than the Maturity Date) upon prior written
      notice as specified under &#8220;Summary &#8212; Issuer Call Feature&#8221; herein. Following an Issuer Call, no further payments will be owed to you under the Notes after the applicable Call Payment Date. Therefore, because the Notes could be called as early as the
      first potential Call Payment Date, the holding period could be limited. If TD does elect to call the Notes prior to maturity, there is no guarantee that you would be able to reinvest the proceeds from an investment in the Notes at a comparable return
      for a similar level of risk. Furthermore, to the extent you are able to reinvest such proceeds in an investment with a comparable return for a similar level of risk, you may incur transaction costs such as dealer discounts and hedging costs built
      into the price of the new notes.</div>
    <div style="text-align: justify;">It is more likely that TD will elect to call the Notes prior to maturity when the expected amounts payable on the Notes, including Contingent Interest Payment(s) and the Payment at Maturity, are greater than the
      amounts that would be payable in the market on other comparable instruments issued by TD with a similar maturity. The greater likelihood of TD calling the Notes in that environment increases the risk that you will not be able to reinvest the proceeds
      from the called Notes in an equivalent investment with a similar Contingent Interest Rate. TD is less likely to call the Notes prior to maturity when the expected amounts payable on the Notes, both Contingent Interest Payments and at maturity, are
      less than the amounts that would be payable in the market on other comparable instruments issued by TD with a similar maturity, which includes periods when the values of any of the Reference Assets are less than their respective Contingent Interest
      Barrier Values and/or their Barrier Values. Therefore, the Notes are more likely to remain outstanding when the expected amount payable on the Notes is less than what would be payable on other comparable instruments and when your risk of not
      receiving a Contingent Interest Payment and/or the Principal Amount at maturity is relatively higher.</div>
    <div> <br>
    </div>
    <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
      <div style="width: 100%;" class="BRPFPageFooter">
        <div>
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;">

              <tr>
                <td style="width: 50.00%;">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-size: 8pt;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50.00%;">
                  <div style="text-align: right; color: rgb(0, 0, 0); font-size: 8pt;">P-<font class="BRPFPageNumber">7</font></div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div style="width: 100%;" class="BRPFPageHeader"></div>
    </div>
    <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">An Investment in Notes With Contingent Interest Payments and an Issuer Call Feature May Be More Sensitive to Interest Rate Risk Than an Investment in Notes Without Such Features.</div>
    <div style="text-align: justify; margin-bottom: 6pt;">Because of the contingent interest and Issuer Call features of the Notes, you will bear greater exposure to fluctuations in interest rates than if you purchased notes without such features. In
      particular, you may be negatively affected if prevailing interest rates begin to rise and the Contingent Interest Rate is, therefore, less than the amount of interest you could earn on other investments with a similar level of risk available at such
      time. In addition, if you tried to sell your Notes at such time, the value of your Notes in any secondary market transaction would also be adversely affected. Conversely, in the event that prevailing interest rates are low relative to the Contingent
      Interest Rate and TD elects to call the Notes, there is a lower likelihood that you will be able to reinvest the proceeds from an investment in the Notes at a comparable rate of return for a similar level of risk.</div>
    <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">The Amounts Payable on the Notes Are Not Linked to the Value of the Least Performing Reference Asset at Any Time Other Than on the Contingent Interest Observation Dates (Including
      the Final Valuation Date).</div>
    <div style="text-align: justify; margin-bottom: 6pt;">Any payments on the Notes will be based on the Closing Value of the Least Performing Reference Asset only on the Contingent Interest Observation Dates (including the Final Valuation Date). Even if
      the value of the Least Performing Reference Asset appreciates prior to a Contingent Interest Observation Date but then drops on that day to a Closing Value that is less than its Contingent Interest Barrier Value, you will not receive any Contingent
      Interest Payment with respect to such Contingent Interest Observation Date. Similarly, the Payment at Maturity may be significantly less than it would have been had the Notes been linked to the Closing Value of the Least Performing Reference Asset on
      a date other than the Final Valuation Date, and may be zero. Although the actual values of the Reference Assets at other times during the term of the Notes may be higher than the values on one or more Contingent Interest Observation Dates (including
      the Final Valuation Date), any Contingent Interest Payments on the Notes and the Payment at Maturity will be based solely on the Closing Value of the Least Performing Reference Asset on the applicable Contingent Interest Observation Date (including
      the Final Valuation Date).</div>
    <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">The Contingent Interest Rate Will Reflect, in Part, the Volatility of Each Reference Asset and May Not Be Sufficient to Compensate You for the Risk of Loss at Maturity.</div>
    <div style="text-align: justify; margin-bottom: 6pt;">Generally, the higher a Reference Asset&#8217;s volatility, the more likely it is that the Closing Value of that Reference Asset could be less than its Contingent Interest Barrier Value on a Contingent
      Interest Observation Date or its Barrier Value on its Final Valuation Date. Volatility means the magnitude and frequency of changes in the value of a Reference Asset. This greater risk will generally be reflected in a higher Contingent Interest Rate
      for the Notes than the interest rate payable on our conventional debt securities with a comparable term. However, while the Contingent Interest Rate is set on the Pricing Date, a Reference Asset&#8217;s volatility can change significantly over the term of
      the Notes, and may increase. The value of any Reference Asset could fall sharply on the Contingent Interest Observation Dates, resulting in few or no Contingent Interest Payments or on the Final Valuation Date, resulting in a loss of a significant
      portion or all of the Principal Amount.</div>
    <div style="text-align: center; margin-bottom: 6pt; font-style: italic; font-weight: bold;">Risks Relating to Characteristics of the Reference Assets</div>
    <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">There Are Market Risks Associated With Each Reference Asset.</div>
    <div style="text-align: justify; margin-bottom: 6pt;">The value of each Reference Asset can rise or fall sharply due to factors specific to such Reference Asset, its Reference Asset Constituents and their issuers (the &#8220;Reference Asset Constituent
      Issuers&#8221;), such as stock price volatility, earnings, financial conditions, corporate, industry and regulatory developments, management changes and decisions and other events, as well as general market factors, such as general stock market volatility
      and levels, interest rates and economic and political conditions. You, as an investor in the Notes, should make your own investigation into the Reference Assets, the Reference Asset Constituents and the Reference Asset Constituent Issuers for your
      Notes. For additional information, see &#8220;Information Regarding the Reference Assets&#8221; in this pricing supplement.</div>
    <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Investors Are Exposed to the Market Risk of Each Reference Asset on Each Contingent Interest Observation Date (Including the Final Valuation Date).</div>
    <div style="text-align: justify;">Your return on the Notes is not linked to a basket consisting of the Reference Assets. Rather, it will be contingent upon the performance of each Reference Asset. Unlike an instrument with a return linked to a basket
      of indices, common stocks or other underlying securities, in which risk is mitigated and diversified among all of the components of the basket, you will be exposed equally to the risks related to each Reference Asset on each Contingent Interest
      Observation Date (including the Final Valuation Date). Poor performance by any Reference Asset over the term of the Notes will negatively affect your return and will not be offset or mitigated by a positive performance by any other Reference Asset.
      For instance, if the Final Value of any Reference Asset is less than its Barrier Value on its Final Valuation Date, you will receive a negative return equal to the Least Performing Percentage Change, even if the Percentage Change of another Reference
      Asset is positive or has not declined as much. Accordingly, your investment is subject to the market risk of each Reference Asset.</div>
    <div> <br>
    </div>
    <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
      <div style="width: 100%;" class="BRPFPageFooter">
        <div>
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;">

              <tr>
                <td style="width: 50.00%;">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-size: 8pt;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50.00%;">
                  <div style="text-align: right; color: rgb(0, 0, 0); font-size: 8pt;">P-<font class="BRPFPageNumber">8</font></div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div style="width: 100%;" class="BRPFPageHeader"></div>
    </div>
    <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Because the Notes Are Linked to the Least Performing Reference Asset, You Are Exposed to a Greater Risk of No Contingent Interest Payments and Losing a Significant Portion or All
      of Your Initial Investment at Maturity Than if the Notes Were Linked to a Single Reference Asset or Fewer Reference Assets.</div>
    <div style="text-align: justify; margin-bottom: 6pt;">The risk that you will not receive any Contingent Interest Payments and lose a significant portion or all of your initial investment in the Notes is greater if you invest in the Notes than the risk
      of investing in substantially similar securities that are linked to the performance of only one Reference Asset or fewer Reference Assets. With more Reference Assets, it is more likely that the Closing Value of any Reference Asset will be less than
      its Contingent Interest Barrier Value on any Contingent Interest Observation Date (including the Final Valuation Date) and that the Final Value of any Reference Asset will be less than its Barrier Value on the Final Valuation Date than if the Notes
      were linked to a single Reference Asset or fewer Reference Assets.</div>
    <div style="text-align: justify; margin-bottom: 6pt;">In addition, the lower the correlation is between the performance of a pair of Reference Assets, the more likely it is that one of the Reference Assets will decline in value to a Closing Value or
      Final Value, as applicable, that is less than its Contingent Interest Barrier Value or Barrier Value on any Contingent Interest Observation Date (including the Final Valuation Date). Although the correlation of the Reference Assets&#8217; performance may
      change over the term of the Notes, the economic terms of the Notes, including the Contingent Interest Rate, Contingent Interest Barrier Value and Barrier Value are determined, in part, based on the correlation of the Reference Assets&#8217; performance
      calculated using our internal models at the time when the terms of the Notes are finalized. All things being equal, a higher Contingent Interest Rate and lower Contingent Interest Barrier Values and Barrier Values are generally associated with lower
      correlation of the Reference Assets. Therefore, if the performance of a pair of Reference Assets is not correlated to each other or is negatively correlated, the risk that you will not receive any Contingent Interest Payments or that the Final Value
      of any Reference Asset is less than its Barrier Value will occur is even greater despite a lower Contingent Interest Barrier Value and Barrier Value, respectively. Therefore, it is more likely that you will not receive any Contingent Interest
      Payments and that you will lose a significant portion or all of your initial investment at maturity.</div>
    <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">We Have No Affiliation With Any Index Sponsor and Will Not Be Responsible for Any Actions Taken by Any Index Sponsor.</div>
    <div style="text-align: justify; margin-bottom: 6pt;">No index sponsor as specified under &#8220;Information Regarding the Reference Assets&#8221; (an &#8220;Index Sponsor&#8221;) is an affiliate of ours and no such entity will be involved in any offering of the Notes in any
      way. Consequently, we have no control of any actions of any Index Sponsor, including any actions of the type that could adversely affect the value of the applicable Reference Asset or any amounts payable on the Notes. No Index Sponsor has any
      obligation of any sort with respect to the Notes. Thus, no Index Sponsor has any obligation to take your interests into consideration for any reason, including in taking any actions that might affect the value of the Notes. None of our proceeds from
      any issuance of the Notes will be delivered to any Index Sponsor, except to the extent that we are required to pay an Index Sponsor licensing fees with respect to the applicable Reference Asset.</div>
    <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Changes that Affect the Reference Assets May Adversely Affect the Market Value of, and Return on, the Notes.</div>
    <div style="text-align: justify; margin-bottom: 6pt;">The policies of each Index Sponsor concerning the calculation of the applicable Reference Asset, additions, deletions or substitutions of the Reference Asset Constituents and the manner in which
      changes affecting those Reference Asset Constituents, such as stock dividends, reorganizations or mergers, may be reflected in the applicable Reference Asset and could adversely affect the market value of, and return on, the Notes. The market value
      of, and return on, the Notes could also be affected if an Index Sponsor changes these policies, for example, by changing the manner in which it calculates the applicable Reference Asset, or if an Index Sponsor discontinues or suspends calculation or
      publication of the applicable Reference Asset. If events such as these occur, the Calculation Agent may select a successor index or take other actions as discussed in the product supplement and, notwithstanding these adjustments, the market value of,
      and return on, the Notes may be adversely affected.</div>
    <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">The Nasdaq-100 Index<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup>, Russell 2000<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index and S&amp;P 500<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index Reflects Price Return, not Total Return.</div>
    <div style="text-align: justify; margin-bottom: 6pt;">The return on the Notes is based on the performance of the Nasdaq-100 Index<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup>, Russell 2000<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index and S&amp;P 500<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index, which reflects the changes in the market
      prices of its Reference Asset Constituents. The Nasdaq-100 Index<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup>, Russell 2000<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index and S&amp;P 500<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index is not a &#8220;total return&#8221; index or strategy, which, in addition to reflecting those price returns, would also
      reflect dividends paid on its Reference Asset Constituents. The return on the Notes will not include such a total return feature or dividend component.</div>
    <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">The Notes are Subject to Risks Associated with Small-Capitalization Companies.</div>
    <div style="text-align: justify;">The Notes are subject to risks associated with small-capitalization companies because the Reference Asset Constituents of the Russell 2000<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index are considered small-capitalization companies. These
      companies often have greater stock price volatility, lower trading volume and less liquidity than large-capitalization companies and therefore such index may be more volatile than an index in which a greater percentage of its constituents are issued
      by large-capitalization companies. Stock prices of small-capitalization companies are also more vulnerable than those of large-capitalization companies to adverse business and economic developments, and the stocks of small-capitalization companies
      may be thinly traded. In addition, small-capitalization companies are typically less stable financially than large-capitalization companies and may depend on a small number of key personnel, making them more vulnerable to loss of personnel.
      Small-capitalization companies are often given less analyst coverage and may be in early, and less predictable, periods of their corporate existences. Such companies tend to have smaller revenues, less diverse product lines, smaller shares of their
      product or service markets, fewer financial resources and less competitive strengths than large-capitalization companies and are more susceptible to adverse developments related to their products.</div>
    <div> <br>
    </div>
    <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
      <div style="width: 100%;" class="BRPFPageFooter">
        <div>
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;">

              <tr>
                <td style="width: 50.00%;">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-size: 8pt;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50.00%;">
                  <div style="text-align: right; color: rgb(0, 0, 0); font-size: 8pt;">P-<font class="BRPFPageNumber">9</font></div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div style="width: 100%;" class="BRPFPageHeader"></div>
    </div>
    <div style="text-align: center; margin-bottom: 6pt; font-style: italic; font-weight: bold;">Risks Relating to Estimated Value and Liquidity</div>
    <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">The Estimated Value of Your Notes Is Less Than the Public Offering Price of Your Notes.</div>
    <div style="text-align: justify; margin-bottom: 6pt;">The estimated value of your Notes is less than the public offering price of your Notes. The difference between the public offering price of your Notes and the estimated value of the Notes reflects
      costs and expected profits associated with selling and structuring the Notes, as well as hedging our obligations under the Notes. Because hedging our obligations entails risks and may be influenced by market forces beyond our control, this hedging
      may result in a profit that is more or less than expected, or a loss.</div>
    <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">The Estimated Value of Your Notes Is Based on Our Internal Funding Rate.</div>
    <div style="text-align: justify; margin-bottom: 6pt;">The estimated value of your Notes is determined by reference to our internal funding rate. The internal funding rate used in the determination of the estimated value of the Notes generally
      represents a discount from the credit spreads for our conventional, fixed-rate debt securities and the borrowing rate we would pay for our conventional, fixed-rate debt securities. This discount is based on, among other things, our view of the
      funding value of the Notes as well as the higher issuance, operational and ongoing liability management costs of the Notes in comparison to those costs for our conventional, fixed-rate debt, as well as estimated financing costs of any hedge
      positions, taking into account regulatory and internal requirements. If the interest rate implied by the credit spreads for our conventional, fixed-rate debt securities, or the borrowing rate we would pay for our conventional, fixed-rate debt
      securities were to be used, we would expect the economic terms of the Notes to be more favorable to you. Additionally, assuming all other economic terms are held constant, the use of an internal funding rate for the Notes is expected to increase the
      estimated value of the Notes at any time.</div>
    <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">The Estimated Value of the Notes Is Based on Our Internal Pricing Models, Which May Prove to Be Inaccurate and May Be Different From the Pricing Models of Other Financial
      Institutions.</div>
    <div style="text-align: justify; margin-bottom: 6pt;">The estimated value of your Notes is based on our internal pricing models when the terms of the Notes are set, which take into account a number of variables, such as our internal funding rate on the
      Pricing Date, and are based on a number of subjective assumptions, which are not evaluated or verified on an independent basis and may or may not materialize. Further, our pricing models may be different from other financial institutions&#8217; pricing
      models and the methodologies used by us to estimate the value of the Notes may not be consistent with those of other financial institutions that may be purchasers or sellers of Notes in the secondary market. As a result, the secondary market price of
      your Notes may be materially less than the estimated value of the Notes determined by reference to our internal pricing models. In addition, market conditions and other relevant factors in the future may change, and any assumptions may prove to be
      incorrect.</div>
    <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">The Estimated Value of Your Notes Is Not a Prediction of the Prices at Which You May Sell Your Notes in the Secondary Market, if Any, and Such Secondary Market Prices, if Any,
      Will Likely Be Less Than the Public Offering Price of Your Notes and May Be Less Than the Estimated Value of Your Notes.</div>
    <div style="text-align: justify; margin-bottom: 6pt;">The estimated value of the Notes is not a prediction of the prices at which the Agent, other affiliates of ours or third parties may be willing to purchase the Notes from you in secondary market
      transactions (if they are willing to purchase, which they are not obligated to do). The price at which you may be able to sell your Notes in the secondary market at any time, if any, will be influenced by many factors that cannot be predicted, such
      as market conditions, and any bid and ask spread for similar sized trades, and may be substantially less than the estimated value of the Notes. Further, as secondary market prices of your Notes take into account the levels at which our debt
      securities trade in the secondary market, and do not take into account our various costs and expected profits associated with selling and structuring the Notes, as well as hedging our obligations under the Notes, secondary market prices of your Notes
      will likely be less than the public offering price of your Notes. As a result, the price at which the Agent, other affiliates of ours or third parties may be willing to purchase the Notes from you in secondary market transactions, if any, will likely
      be less than the price you paid for your Notes, and any sale prior to the Maturity Date could result in a substantial loss to you.</div>
    <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">The Temporary Price at Which the Agent May Initially Buy the Notes in the Secondary Market May Not Be Indicative of Future Prices of Your Notes.</div>
    <div style="text-align: justify; margin-bottom: 6pt;">Assuming that all relevant factors remain constant after the Pricing Date, the price at which the Agent may initially buy or sell the Notes in the secondary market (if the Agent makes a market in
      the Notes, which it is not obligated to do) may exceed the estimated value of the Notes on the Pricing Date, as well as the secondary market value of the Notes, for a temporary period after the Issue Date of the Notes, as discussed further under
      &#8220;Additional Information Regarding the Estimated Value of the Notes.&#8221; The price at which the Agent may initially buy or sell the Notes in the secondary market may not be indicative of future prices of your Notes.</div>
    <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">The Underwriting Discount, Offering Expenses and Certain Hedging Costs Are Likely to Adversely Affect Secondary Market Prices.</div>
    <div style="text-align: justify;">Assuming no changes in market conditions or any other relevant factors, the price, if any, at which you may be able to sell the Notes will likely be less than the public offering price. The public offering price
      includes, and any price quoted to you is likely to exclude, any underwriting discount paid in connection with the initial distribution, offering expenses as well as the cost of hedging our obligations under the Notes. In addition, any such price is
      also likely to reflect dealer discounts, mark-ups and other transaction costs, such as a discount to account for costs associated with establishing or unwinding any related hedge transaction.</div>
    <div> <br>
    </div>
    <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
      <div style="width: 100%;" class="BRPFPageFooter">
        <div>
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;">

              <tr>
                <td style="width: 50.00%;">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-size: 8pt;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50.00%;">
                  <div style="text-align: right; color: rgb(0, 0, 0); font-size: 8pt;">P-<font class="BRPFPageNumber">10</font></div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div style="width: 100%;" class="BRPFPageHeader"></div>
    </div>
    <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">There May Not Be an Active Trading Market for the Notes &#8212; Sales in the Secondary Market May Result in Significant Losses.</div>
    <div style="text-align: justify; margin-bottom: 6pt;">There may be little or no secondary market for the Notes. The Notes will not be listed or displayed on any securities exchange or electronic communications network. The Agent or another one of our
      affiliates may make a market for the Notes; however, it is not required to do so and may stop any market-making activities at any time. Even if a secondary market for the Notes develops, it may not provide significant liquidity or trade at prices
      advantageous to you. We expect that transaction costs in any secondary market would be high. As a result, the difference between bid and ask prices for your Notes in any secondary market could be substantial.</div>
    <div style="text-align: justify; margin-bottom: 6pt;">Furthermore, TD&#8217;s right to call the Notes prior to maturity may adversely impact your ability to sell your Notes in the secondary market. If you are able to sell your Notes before the Maturity Date,
      you may have to do so at a substantial discount from the public offering price irrespective of the value of the then-current least performing Reference Asset, and as a result, you may suffer substantial losses.</div>
    <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">If the Value of Any Reference Asset Changes, the Market Value of Your Notes May Not Change in the Same Manner.</div>
    <div style="text-align: justify; margin-bottom: 6pt;">Your Notes may trade quite differently from the performance of any of the Reference Assets. Changes in the value of any Reference Asset may not result in a comparable change in the market value of
      your Notes. Even if the Closing Value of each Reference Asset remains greater than or equal to its Barrier Value and Contingent Interest Barrier Value or increases to greater than its Initial Value during the term of the Notes, the market value of
      your Notes may not increase by the same amount and could decline.</div>
    <div style="text-align: center; margin-bottom: 6pt; font-style: italic; font-weight: bold;">Risks Relating to Hedging Activities and Conflicts of Interest</div>
    <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">There Are Potential Conflicts of Interest Between You and the Calculation Agent.</div>
    <div style="text-align: justify; margin-bottom: 6pt;">The Calculation Agent will, among other things, determine the amounts payable on the Notes. We will serve as the Calculation Agent and may appoint a different Calculation Agent after the Issue Date
      without notice to you. Moreover, we may elect to call the Notes pursuant to the Issuer Call Feature. If we do elect to call the Notes prior to maturity, such decision may be based on factors that make an Issuer Call at that time less favorable to
      you. The Calculation Agent will exercise its judgment when performing its functions and may have a conflict of interest if it needs to make certain decisions. For example, the Calculation Agent may have to determine whether a market disruption event
      affecting a Reference Asset has occurred, and make certain adjustments if certain events occur, which may, in turn, depend on the Calculation Agent&#8217;s judgment as to whether the event has materially interfered with our ability or the ability of one of
      our affiliates to unwind our hedge positions. Because this determination by the Calculation Agent may affect the amounts payable on the Notes, the Calculation Agent may have a conflict of interest if it needs to make a determination of this kind. For
      additional information on the Calculation Agent&#8217;s role, see &#8220;General Terms of the Notes &#8212; Role of Calculation Agent&#8221; in the product supplement.</div>
    <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">The Contingent Interest Observation Dates (Including the Final Valuation Date) and the Related Payment Dates Are Subject to Market Disruption Events and Postponements.</div>
    <div style="text-align: justify; margin-bottom: 6pt;">Each Contingent Interest Observation Date (including the Final Valuation Date) and related payment date (including the Maturity Date) is subject to postponement due to the occurrence of one or more
      market disruption events. For a description of what constitutes a market disruption event as well as the consequences of that market disruption event, see &#8220;General Terms of the Notes &#8212; Market Disruption Events&#8221; in the product supplement. A market
      disruption event for a particular Reference Asset will not constitute a market disruption event for any other Reference Asset.</div>
    <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Trading and Business Activities by TD or Its Affiliates May Adversely Affect the Market Value Of, and Any Amounts Payable On, the Notes.</div>
    <div style="text-align: justify; margin-bottom: 6pt;">We, the Agent and/or our other affiliates may hedge our obligations under the Notes by purchasing securities, futures, options or other derivative instruments with returns linked or related to
      changes in the value of a Reference Asset or one or more Reference Asset Constituents, and we may adjust these hedges by, among other things, purchasing or selling at any time any of the foregoing assets. It is possible that we or one or more of our
      affiliates could receive substantial returns from these hedging activities while the market value of the Notes declines. We or one or more of our affiliates may also issue or underwrite other securities or financial or derivative instruments with
      returns linked or related to changes in a Reference Asset or one or more Reference Asset Constituents.</div>
    <div style="text-align: justify; margin-bottom: 6pt;">These trading activities may present a conflict between the holders&#8217; interest in the Notes and the interests we and our affiliates will have in our or their proprietary accounts, in facilitating
      transactions, including options and other derivatives transactions, for our or their customers&#8217; accounts and in accounts under our or their management. These trading activities could be adverse to the interests of the holders of the Notes.</div>
    <div style="text-align: justify;"><font style="color: #000000;">We, the Agent and/or our other affiliates may, </font>at present or in the future, engage in business with one or more Reference Asset Constituent Issuers, including making loans to or
      providing advisory services to those companies. These services could include investment banking and merger and acquisition advisory services. These business activities may present a conflict between <font style="color: #000000;">our, the Agent&#8217;s
        and/or our other affiliates&#8217; obligations</font>, and your interests as a holder of the Notes. Moreover, we, the Agent and/or our <font style="color: #000000;">other </font>affiliates may have published, and in the future expect to publish,
      research reports with respect to a Reference Asset or one or more Reference Asset Constituents. This research is modified from time to time without notice and may express opinions or provide recommendations that are inconsistent with purchasing or
      holding the Notes. Any of these activities by us and/or our <font style="color: #000000;">other </font>affiliates may affect the value of a Reference Asset and, therefore, the market value of, and any amounts payable on, the Notes. Further, TD is
      less likely to call the Notes when the Closing Value of any Reference Asset is less than its Contingent Interest Barrier Value and, therefore, any hedging activities that adversely affect the value of a Reference Asset may also diminish the
      probability of TD calling the Notes.</div>
    <div> <br>
    </div>
    <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
      <div style="width: 100%;" class="BRPFPageFooter">
        <div>
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;">

              <tr>
                <td style="width: 50.00%;">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-size: 8pt;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50.00%;">
                  <div style="text-align: right; color: rgb(0, 0, 0); font-size: 8pt;">P-<font class="BRPFPageNumber">11</font></div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div style="width: 100%;" class="BRPFPageHeader"></div>
    </div>
    <div style="text-align: center; margin-bottom: 6pt; font-style: italic; font-weight: bold;">Risks Relating to General Credit Characteristics</div>
    <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Investors Are Subject to TD&#8217;s Credit Risk, and TD&#8217;s Credit Ratings and Credit Spreads May Adversely Affect the Market Value of the Notes.</div>
    <div style="text-align: justify; margin-bottom: 6pt;">Although the return on the Notes will be based on the performance of the Least Performing Reference Asset, the payment of any amount due on the Notes is subject to TD&#8217;s credit risk. The Notes are
      TD&#8217;s senior unsecured debt obligations. Investors are dependent on TD&#8217;s ability to pay all amounts due on the Notes and, therefore, investors are subject to the credit risk of TD and to changes in the market&#8217;s view of TD&#8217;s creditworthiness. Any
      decrease in TD&#8217;s credit ratings or increase in the credit spreads charged by the market for taking TD&#8217;s credit risk is likely to adversely affect the market value of the Notes. If TD becomes unable to meet its financial obligations as they become
      due, investors may not receive any amounts due under the terms of the Notes.</div>
    <div style="text-align: center; margin-bottom: 6pt; font-style: italic; font-weight: bold;">Risks Relating to Canadian and U.S. Federal Income Taxation</div>
    <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Significant Aspects of the Tax Treatment of the Notes Are Uncertain.</div>
    <div style="text-align: justify; margin-bottom: 6pt;">The U.S. tax treatment of the Notes is uncertain. Please read carefully the section entitled &#8220;Material U.S. Federal Income Tax Consequences&#8221; herein and in the product supplement. You should consult
      your tax advisor as to the tax consequences of your investment in the Notes.</div>
    <div style="text-align: justify;">For a discussion of the Canadian federal income tax consequences of investing in the Notes, please see the discussion in the prospectus under &#8220;Tax Consequences &#8212; Canadian Taxation&#8221; and in the product supplement under
      &#8220;Supplemental Discussion of Canadian Tax Consequences&#8221; and the further discussion herein under &#8220;Summary&#8221;. If you are not a Non-resident Holder (as that term is defined in the prospectus) for Canadian federal income tax purposes or if you acquire the
      Notes in the secondary market, you should consult your tax advisors as to the consequences of acquiring, holding and disposing of the Notes and receiving the payments that might be due under the Notes.</div>
    <div> <br>
    </div>
    <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
      <div style="width: 100%;" class="BRPFPageFooter">
        <div>
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;">

              <tr>
                <td style="width: 50.00%;">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-size: 8pt;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50.00%;">
                  <div style="text-align: right; color: rgb(0, 0, 0); font-size: 8pt;">P-<font class="BRPFPageNumber">12</font></div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div style="width: 100%;" class="BRPFPageHeader"></div>
    </div>
    <div style="text-align: justify; margin-bottom: 6pt; color: rgb(0, 176, 80); font-size: 16pt;">Hypothetical Returns</div>
    <div style="text-align: justify; margin-top: 6pt;">The examples set out below are included for illustration purposes only and are hypothetical examples only; amounts below may have been rounded for ease of analysis. The hypothetical Initial Values,
      Closing Values, Final Values and<font style="font-weight: bold;">&#160;</font>Percentage Changes of the Reference Assets used to illustrate the calculation of whether a Contingent Interest Payment is payable on a Contingent Interest Payment Date and the
      Payment at Maturity are not estimates or forecasts of the actual Initial Value, Closing Value or Final Value of any Reference Asset, or the value of any Reference Asset on any Trading Day prior to the Maturity Date. All examples assume, for Reference
      Asset A, Reference Asset B and Reference Asset C, respectively, Initial Values of 25,000.00, 2,500.00 and 6,500.00, Contingent Interest Barrier Values of 18,750.00, 1,875.00 and 4,875.00 (each 75.00% of its Initial Value), Barrier Values of
      15,000.00, 1,500.00 and 3,900.00 (each 60.00% of its Initial Value), a Contingent Interest Payment of $5.792 per Note (reflecting the Contingent Interest Rate of approximately 6.95% per annum), Call Payment Dates monthly, commencing on the twelfth
      Contingent Interest Payment Date and other than the Maturity Date, that a holder purchased Notes with a Principal Amount of $1,000 and that no market disruption event occurs on any Contingent Interest Observation Date (including the Final Valuation
      Date). The actual terms of the Notes are set forth elsewhere in this pricing supplement.</div>
    <div style="text-align: justify; margin-top: 6pt; font-weight: bold;">Example 1 &#8212; TD Elects to Call the Notes on the First Potential Call Payment Date.</div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z9f85893776e6403ab3c3988e3f3a1bb8">

        <tr>
          <td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 18%;">
            <div>
              <div style="text-align: center; margin-top: 3pt; font-weight: bold;">Date</div>
            </div>
          </td>
          <td style="vertical-align: top; width: 1%; padding-bottom: 1px;">&#160;</td>
          <td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 50%;">
            <div>
              <div style="text-align: center; margin-top: 3pt; font-weight: bold;">Closing Values</div>
            </div>
          </td>
          <td style="vertical-align: top; width: 1%; padding-bottom: 1px;">&#160;</td>
          <td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 30%;">
            <div>
              <div style="text-align: center; margin-top: 3pt; font-weight: bold;">Payment (per Note)</div>
            </div>
          </td>
        </tr>
        <tr>
          <td style="width: 18%; vertical-align: top;">
            <div style="margin-top: 3pt;">First through Eleventh Contingent Interest Observation Date</div>
          </td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 50%; vertical-align: top;">
            <div style="margin-top: 3pt;">Reference Asset A: Various (all <font style="font-weight: bold;">greater than or equal to</font> its Contingent Interest Barrier Value)</div>
            <div style="margin-top: 3pt;">Reference Asset B: Various (all <font style="font-weight: bold;">greater than or equal to</font> its Contingent Interest Barrier Value)</div>
            <div style="margin-top: 3pt;">Reference Asset C: Various (all <font style="font-weight: bold;">greater than or equal to</font> its Contingent Interest Barrier Value)</div>
          </td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 30%; vertical-align: top;">
            <div style="margin-top: 3pt;">$63.712 (Aggregate Contingent Interest Payments &#8211; Not Callable)</div>
          </td>
        </tr>
        <tr>
          <td style="width: 18%; vertical-align: top;">
            <div style="margin-top: 3pt;">Twelfth Contingent Interest Observation Date</div>
          </td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 50%; vertical-align: top;">
            <div style="margin-top: 3pt;">Reference Asset A: 17,812.50 (<font style="font-weight: bold;">less than</font> its Contingent Interest Barrier Value)</div>
            <div style="margin-top: 3pt;">Reference Asset B: 2,250.00 (<font style="font-weight: bold;">greater than or equal to</font> its Contingent Interest Barrier Value)</div>
            <div style="margin-top: 3pt;">Reference Asset C: 5,525.00 (<font style="font-weight: bold;">greater than or equal to</font> its Contingent Interest Barrier Value)</div>
          </td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 30%; vertical-align: top;">
            <div style="margin-top: 6pt;">$1,000.00 (Total Payment upon Issuer Call)</div>
          </td>
        </tr>
        <tr>
          <td style="width: 18%; vertical-align: top;">&#160;</td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 50%; vertical-align: top;">
            <div style="text-align: right; margin-top: 3pt;">Total Payment:</div>
          </td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 30%; vertical-align: top;">
            <div style="margin-top: 3pt;">$1,063.712 (6.3712% total return)</div>
          </td>
        </tr>

    </table>
    <div style="text-align: justify;">Because TD elects to call the Notes on the first potential Call Payment Date (which is also the twelfth Contingent Interest Payment Date) and the Closing Value of at least one Reference Asset is less than its
      Contingent Interest Barrier Value on the corresponding Contingent Interest Observation Date, on the Call Payment Date, we will pay you a cash payment equal to $1,000.00 per Note, reflecting the Principal Amount. When added to the Contingent Interest
      Payments of $63.712 paid in respect of the prior Contingent Interest Payment Dates, TD will have paid you a total of $1,063.712 per Note, for a total return of 6.3712% on the Notes. No further amounts will be owed under the Notes.</div>
    <div> <br>
    </div>
    <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
      <div style="width: 100%;" class="BRPFPageFooter">
        <div>
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;">

              <tr>
                <td style="width: 50.00%;">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-size: 8pt;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50.00%;">
                  <div style="text-align: right; color: rgb(0, 0, 0); font-size: 8pt;">P-<font class="BRPFPageNumber">13</font></div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div style="width: 100%;" class="BRPFPageHeader"></div>
    </div>
    <div style="text-align: justify; margin-top: 6pt; font-weight: bold;">Example 2 &#8212; The Closing Value of at Least One Reference Asset Is Less Than Its Contingent Interest Barrier Value on Each Contingent Interest Observation Date Prior to the Final
      Valuation Date, TD Does NOT Elect to Call the Notes Prior to Maturity and the Final Value of Each Reference Asset Is Greater Than or Equal to Its Barrier Value and Contingent Interest Barrier Value.</div>
    <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z9dbabd70f4bd49a48c1b09cfd31773d1">

        <tr>
          <td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 18%;">
            <div>
              <div style="text-align: center; margin-top: 3pt; font-weight: bold;">Date</div>
            </div>
          </td>
          <td style="vertical-align: top; width: 1%; padding-bottom: 1px;">&#160;</td>
          <td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 50%;">
            <div>
              <div style="text-align: center; margin-top: 3pt; font-weight: bold;">Closing Values</div>
            </div>
          </td>
          <td style="vertical-align: top; width: 1%; padding-bottom: 1px;">&#160;</td>
          <td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 30%;">
            <div>
              <div style="text-align: center; margin-top: 3pt; font-weight: bold;">Payment (per Note)</div>
            </div>
          </td>
        </tr>
        <tr>
          <td style="width: 18%; vertical-align: top;">
            <div style="margin-top: 3pt;">First through Eleventh Contingent Interest Observation Date</div>
          </td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 50%; vertical-align: top;">
            <div style="margin-top: 3pt;">Reference Asset A: Various (all <font style="font-weight: bold;">less than</font> its Contingent Interest Barrier Value)</div>
            <div style="margin-top: 3pt;">Reference Asset B: Various (all <font style="font-weight: bold;">greater than or equal to</font> its Contingent Interest Barrier Value)</div>
            <div style="margin-top: 3pt;">Reference Asset C: Various (all <font style="font-weight: bold;">greater than or equal to</font> its Contingent Interest Barrier Value)</div>
          </td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 30%; vertical-align: top;">
            <div style="margin-top: 3pt;">$0.00</div>
          </td>
        </tr>
        <tr>
          <td style="width: 18%; vertical-align: top;">
            <div style="margin-top: 3pt;">Twelfth through Fifty-Ninth Contingent Interest Observation Date</div>
          </td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 50%; vertical-align: top;">
            <div style="margin-top: 3pt;">Reference Asset A: Various (all <font style="font-weight: bold;">greater than or equal to</font> its Contingent Interest Barrier Value)</div>
            <div style="margin-top: 3pt;">Reference Asset B: Various (all <font style="font-weight: bold;">less than</font> its Contingent Interest Barrier Value)</div>
            <div style="margin-top: 3pt;">Reference Asset C: Various (all <font style="font-weight: bold;">greater than or equal to</font> its Contingent Interest Barrier Value)</div>
          </td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 30%; vertical-align: top;">
            <div style="margin-top: 3pt;">$0.00</div>
          </td>
        </tr>
        <tr>
          <td style="width: 18%; vertical-align: top;">
            <div style="margin-top: 3pt;">Final Valuation Date</div>
          </td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 50%; vertical-align: top;">
            <div style="margin-top: 3pt;">Reference Asset A: 30,000.00 (<font style="font-weight: bold;">greater than or equal to</font> its Contingent Interest Barrier Value and Barrier Value)</div>
            <div style="margin-top: 3pt;">Reference Asset B: 2,625.00 (<font style="font-weight: bold;">greater than or equal to</font> its Contingent Interest Barrier Value and Barrier Value)</div>
            <div style="margin-top: 3pt;">Reference Asset C: 7,475.00 (<font style="font-weight: bold;">greater than or equal to</font> its Contingent Interest Barrier Value and Barrier Value)</div>
          </td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 30%; vertical-align: top;">
            <div style="margin-top: 6pt;">$1,000.00 (Principal Amount)</div>
            <div><u>+ $5.792</u> (Contingent Interest Payment)</div>
            <div>$1,005.792 (Total Payment on Maturity Date)</div>
          </td>
        </tr>
        <tr>
          <td style="width: 18%; vertical-align: top;">&#160;</td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 50%; vertical-align: top;">
            <div style="text-align: right; margin-top: 3pt;">Total Payment:</div>
          </td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 30%; vertical-align: top;">
            <div style="margin-top: 3pt;">$1,005.792 (0.5792% total return)</div>
          </td>
        </tr>

    </table>
    <div style="text-align: justify; margin-top: 6pt;">Because TD does not elect to call the Notes prior to maturity and the Closing Value of at least one Reference Asset on each Contingent Interest Observation Date prior to the Final Valuation Date is
      less than its Contingent Interest Barrier Value, we will not pay the Contingent Interest Payment on any of the corresponding Contingent Interest Payment Dates and the Notes will not be subject to an Issuer Call. Because the Final Value of each
      Reference Asset is greater than or equal to its Barrier Value and Contingent Interest Barrier Value, on the Maturity Date we will pay you a cash payment equal to $1,005.792 per Note, reflecting your Principal Amount plus the applicable Contingent
      Interest Payment, for a total return of 0.5792% on the Notes.</div>
    <div style="text-align: justify; margin-top: 6pt; font-weight: bold;">Example 3 &#8212; The Closing Value of at Least One Reference Asset Is Less Than Its Contingent Interest Barrier Value on Each Contingent Interest Observation Date Prior to the Final
      Valuation Date, TD Does NOT Elect to Call the Notes Prior to Maturity,</div>
    <div style="font-weight: 400;"> <br>
    </div>
    <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
      <div style="width: 100%;" class="BRPFPageFooter">
        <div>
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;">

              <tr>
                <td style="width: 50.00%;">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-size: 8pt;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50.00%;">
                  <div style="text-align: right; color: rgb(0, 0, 0); font-size: 8pt;">P-<font class="BRPFPageNumber">14</font></div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div style="width: 100%;" class="BRPFPageHeader"></div>
    </div>
    <div style="text-align: justify; margin-top: 6pt; font-weight: bold;">the Final Value of Each Reference Asset Is Greater Than or Equal to Its Barrier Value and the Final Value of Any Reference Asset Is Less Than Its Contingent Interest Barrier Value.</div>
    <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z11e4ab2b68b1410390367ccbc5f70925">

        <tr>
          <td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 18%;">
            <div>
              <div style="text-align: center; margin-top: 3pt; font-weight: bold;">Date</div>
            </div>
          </td>
          <td style="vertical-align: top; width: 1%; padding-bottom: 1px;">&#160;</td>
          <td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 50%;">
            <div>
              <div style="text-align: center; margin-top: 3pt; font-weight: bold;">Closing Values</div>
            </div>
          </td>
          <td style="width: 1%; vertical-align: top; padding-bottom: 1px;">&#160;</td>
          <td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 30%;">
            <div>
              <div style="text-align: center; margin-top: 3pt; font-weight: bold;">Payment (per Note)</div>
            </div>
          </td>
        </tr>
        <tr>
          <td style="width: 18%; vertical-align: top;">
            <div style="margin-top: 3pt;">First through Eleventh Contingent Interest Observation Date</div>
          </td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 50%; vertical-align: top;">
            <div style="margin-top: 3pt;">Reference Asset A: Various (all <font style="font-weight: bold;">greater than or equal to</font> its Contingent Interest Barrier Value)</div>
            <div style="margin-top: 3pt;">Reference Asset B: Various (all <font style="font-weight: bold;">less than</font> its Contingent Interest Barrier Value)</div>
            <div style="margin-top: 3pt;">Reference Asset C: Various (all <font style="font-weight: bold;">greater than or equal to</font> its Contingent Interest Barrier Value)</div>
          </td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 30%; vertical-align: top;">
            <div style="margin-top: 3pt;">$0.00</div>
          </td>
        </tr>
        <tr>
          <td style="width: 18%; vertical-align: top;">
            <div style="margin-top: 3pt;">Twelfth through Fifty-Ninth Contingent Interest Observation Date</div>
          </td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 50%; vertical-align: top;">
            <div style="margin-top: 3pt;">Reference Asset A: Various (all <font style="font-weight: bold;">less than</font> its Contingent Interest Barrier Value)</div>
            <div style="margin-top: 3pt;">Reference Asset B: Various (all <font style="font-weight: bold;">greater than or equal to</font> its Contingent Interest Barrier Value)</div>
            <div style="margin-top: 3pt;">Reference Asset C: Various (all <font style="font-weight: bold;">greater than or equal to</font> its Contingent Interest Barrier Value)</div>
          </td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 30%; vertical-align: top;">
            <div style="margin-top: 3pt;">$0.00</div>
          </td>
        </tr>
        <tr>
          <td style="width: 18%; vertical-align: top;">
            <div>&#160;</div>
            <div style="margin-top: 3pt;">Final Valuation Date</div>
          </td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 50%; vertical-align: top;">
            <div>&#160;</div>
            <div style="margin-top: 3pt;">Reference Asset A: 15,000.00 (<font style="font-weight: bold;">less than</font> its Contingent Interest Barrier Value; <font style="font-weight: bold;">greater than or equal to</font> its Barrier Value)</div>
            <div style="margin-top: 3pt;">Reference Asset B: 2,375.00 (<font style="font-weight: bold;">greater than or equal to</font> its Contingent Interest Barrier Value and Barrier Value)</div>
            <div style="margin-top: 3pt;">Reference Asset C: 5,525.00 (<font style="font-weight: bold;">greater than or equal to</font> its Contingent Interest Barrier Value and Barrier Value)</div>
          </td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 30%; vertical-align: top;">
            <div>&#160;</div>
            <div style="margin-top: 3pt;">$1,000.00 (Payment at Maturity)</div>
          </td>
        </tr>
        <tr>
          <td style="width: 18%; vertical-align: top;">&#160;</td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 50%; vertical-align: top;">
            <div style="text-align: right; margin-top: 3pt;">Total Payment:</div>
          </td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 30%; vertical-align: top;">
            <div style="margin-top: 3pt;">$1,000.00 (0.00% total return)</div>
          </td>
        </tr>

    </table>
    <div style="text-align: justify; margin-top: 6pt;">Because TD does not elect to call the Notes prior to maturity and the Closing Value of at least one Reference Asset on each Contingent Interest Observation Date prior to the Final Valuation Date is
      less than its Contingent Interest Barrier Value, we will not pay the Contingent Interest Payment on any of the corresponding Contingent Interest Payment Dates and the Notes will not be subject to an Issuer Call. Because the Final Value of each
      Reference Asset is greater than or equal to its Barrier Value and the Final Value of at least one Reference Asset is less than its Contingent Interest Barrier Value, on the Maturity Date we will pay you a cash payment equal to $1,000.00, reflecting
      your Principal Amount, for a total return of 0.00% on the Notes.</div>
    <div style="text-align: justify; margin-top: 6pt; font-weight: bold;">Example 4 &#8212; The Closing Value of at Least One Reference Asset Is Less Than Its Contingent Interest Barrier Value on Each Contingent Interest Observation Date Prior to the Final
      Valuation Date, TD Does NOT Elect to Call the Notes Prior to Maturity and the Final Value of at Least One Reference Asset Is Less Than Its Contingent Interest Barrier Value and Barrier Value.</div>
    <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zaea1b6426d5442439d3a621e4aea19ee">

        <tr>
          <td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 18%;">
            <div>
              <div style="text-align: center; margin-top: 3pt; font-weight: bold;">Date</div>
            </div>
          </td>
          <td style="vertical-align: top; width: 1%; padding-bottom: 1px;">&#160;</td>
          <td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 50%;">
            <div>
              <div style="text-align: center; margin-top: 3pt; font-weight: bold;">Closing Values</div>
            </div>
          </td>
          <td style="vertical-align: top; width: 1%; padding-bottom: 1px;">&#160;</td>
          <td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 30%;">
            <div>
              <div style="text-align: center; margin-top: 3pt; font-weight: bold;">Payment (per Note)</div>
            </div>
          </td>
        </tr>
        <tr>
          <td style="width: 18%; vertical-align: top;">
            <div style="margin-top: 3pt;">First through Eleventh Contingent Interest Observation Date</div>
          </td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 50%; vertical-align: top;">
            <div style="margin-top: 3pt;">Reference Asset A: Various (all <font style="font-weight: bold;">less than</font> its Contingent Interest Barrier Value)</div>
            <div style="margin-top: 3pt;">Reference Asset B: Various (all <font style="font-weight: bold;">greater than or equal to</font> its Contingent Interest Barrier Value)</div>
            <div style="margin-top: 3pt;">Reference Asset C: Various (all <font style="font-weight: bold;">greater than or equal to</font> its Contingent Interest Barrier Value)</div>
          </td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 30%; vertical-align: top;">
            <div style="margin-top: 3pt;">$0.00</div>
          </td>
        </tr>
        <tr>
          <td style="width: 18%; vertical-align: top;">
            <div style="margin-top: 3pt;">Twelfth through Fifty-Ninth Contingent Interest Observation Date</div>
          </td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 50%; vertical-align: top;">
            <div style="margin-top: 3pt;">Reference Asset A: Various (all <font style="font-weight: bold;">greater than or equal to</font> its Contingent Interest Barrier Value)</div>
            <div style="margin-top: 3pt;">Reference Asset B: Various (all<font style="font-weight: bold;"> less than</font> its Contingent Interest Barrier Value)</div>
            <div style="margin-top: 3pt;">Reference Asset C: Various (all <font style="font-weight: bold;">greater than or equal to</font> its Contingent Interest Barrier Value)</div>
          </td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 30%; vertical-align: top;">
            <div style="margin-top: 3pt;">$0.00</div>
          </td>
        </tr>
        <tr>
          <td style="width: 18%; vertical-align: top;">
            <div style="margin-top: 3pt;">Final Valuation Date</div>
          </td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 50%; vertical-align: top;">
            <div style="margin-top: 3pt;">Reference Asset A: 10,000.00 (<font style="font-weight: bold;">less than</font> its Contingent Interest Barrier Value and Barrier Value)</div>
            <div style="margin-top: 3pt;">Reference Asset B: 3,125.00 (<font style="font-weight: bold;">greater than or equal to</font> its Contingent Interest Barrier Value and Barrier Value)</div>
            <div style="margin-top: 3pt;">Reference Asset C: 7,150.00 (<font style="font-weight: bold;">greater than or equal to</font> its Contingent Interest Barrier Value and Barrier Value)</div>
          </td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 30%; vertical-align: top;">
            <div style="margin-top: 3pt;">$1,000 + ($1,000 &#215; Least Performing Percentage Change) =</div>
            <div style="margin-top: 3pt;">$1,000 + ($1,000 &#215; -60.00%) =</div>
            <div style="margin-top: 3pt;">$400.00</div>
            <div style="margin-top: 3pt;">(Payment at Maturity)</div>
          </td>
        </tr>
        <tr>
          <td style="width: 18%; vertical-align: top;">&#160;</td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 50%; vertical-align: top;">
            <div style="text-align: right; margin-top: 3pt;">Total Payment:</div>
          </td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 30%; vertical-align: top;">
            <div style="margin-top: 3pt;">$400.00 (60.00% loss)</div>
          </td>
        </tr>

    </table>
    <div style="text-align: justify; margin-top: 6pt;">Because TD does not elect to call the Notes prior to maturity and the Closing Value of at least one Reference Asset on each Contingent Interest Observation Date prior to the Final Valuation Date is
      less than its Contingent Interest Barrier Value, we will not pay the Contingent Interest Payment on any of the corresponding Contingent Interest Payment Dates and the Notes will not be subject to an Issuer Call.</div>
    <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
      <div style="width: 100%;" class="BRPFPageFooter">
        <div>
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;">

              <tr>
                <td style="width: 50.00%;">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-size: 8pt;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50.00%;">
                  <div style="text-align: right; color: rgb(0, 0, 0); font-size: 8pt;">P-<font class="BRPFPageNumber">15</font></div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div style="width: 100%;" class="BRPFPageHeader"></div>
    </div>
    <div style="text-align: justify; margin-top: 6pt;">Because the Final Value of at least one Reference Asset is less than its Contingent Interest Barrier Value and Barrier Value, on the Maturity Date we will pay you a cash payment that is less than the
      Principal Amount, if anything, equal to the Principal Amount plus the product of the Principal Amount and the Least Performing Percentage Change,<font style="font-size: 8pt;">&#160;</font>for a total of $400.00 per Note, a loss of 60.00% per Note.</div>
    <div style="text-align: justify; margin-top: 6pt; font-weight: bold;">In this scenario, investors will suffer a percentage loss on their initial investment that is equal to the Least Performing Percentage Change. Specifically, investors will lose 1% of
      the Principal Amount of the Notes for each 1% that the Final Value of the Least Performing Reference Asset is less than its Initial Value, and may lose the entire Principal Amount.</div>
    <div style="margin: 6pt 0px 0px; font-weight: bold; text-align: justify;">&#160;Any payments on the Notes are subject to our credit risk.</div>
    <div style="font-weight: 400;"> <br>
    </div>
    <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
      <div style="width: 100%;" class="BRPFPageFooter">
        <div>
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;">

              <tr>
                <td style="width: 50.00%;">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-size: 8pt;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50.00%;">
                  <div style="text-align: right; color: rgb(0, 0, 0); font-size: 8pt;">P-<font class="BRPFPageNumber">16</font></div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div style="width: 100%;" class="BRPFPageHeader"></div>
    </div>
    <div style="text-align: justify; margin-top: 6pt; margin-bottom: 6pt; color: rgb(0, 176, 80); font-size: 16pt;">Information Regarding the Reference Assets</div>
    <div style="text-align: justify; margin-bottom: 6pt;">All disclosures contained in this document regarding the Reference Assets, including, without limitation, their make-up, methods of calculation, and changes in any Reference Asset Constituents, have
      been derived from publicly available sources. We have not undertaken an independent review or due diligence of any publicly available information with respect to any Reference Asset. The information reflects the policies of, and is subject to change
      by, the Index Sponsors. Each Index Sponsor, owns the copyright and all other rights to the relevant Reference Asset, has no obligation to continue to publish, and may discontinue publication of, the relevant Reference Asset. None of the websites
      referenced in the Reference Asset descriptions below, or any materials included in those websites, are incorporated by reference into this document or any document incorporated herein by reference.</div>
    <div style="text-align: justify; margin-bottom: 6pt;">The graphs below set forth the information relating to the historical performance of each Reference Asset. The graphs below show the daily historical Closing Values of each Reference Asset for the
      periods specified. We obtained the information regarding the historical performance of each Reference Asset in the graphs below from Bloomberg.</div>
    <div style="text-align: justify; margin-bottom: 6pt;">We have not independently verified the accuracy or completeness of the information obtained from Bloomberg. The historical performance of each Reference Asset should not be taken as an indication of
      its future performance, and no assurance can be given as to the Final Value of any Reference Asset. We cannot give you any assurance that the performance of the Reference Assets will result in a positive return on your initial investment.</div>
    <div style="text-align: justify; margin-top: 6pt; font-weight: bold;">
      <div>
        <table cellspacing="0" cellpadding="0" border="0" style="border-collapse: collapse; margin: 0px 0px 6pt; width: 5%; color: #000000; font-family: Arial; font-size: 9pt; text-align: left;">

            <tr>
              <td nowrap="nowrap" style="width: 5%; vertical-align: top; border-bottom: 1px solid rgb(0, 0, 0);"><font style="font-weight: bold;">Nasdaq-100 Index<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup></font> </td>
            </tr>

        </table>
      </div>
    </div>
    <div style="text-align: justify; margin-top: 6pt;">We have derived all information regarding the Nasdaq-100 Index<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> (&#8220;NDX&#8221;) contained in this document, including, without limitation, its make-up, method of calculation and changes in its
      components, from publicly available information. Such information reflects the policies of, and is subject to change by Nasdaq, Inc. and its affiliates (collectively, &#8220;Nasdaq&#8221;) (its &#8220;Index Sponsor&#8221; or &#8220;Nasdaq&#8221;).</div>
    <div style="text-align: justify; margin-top: 6pt;">NDX is published by Nasdaq, but Nasdaq has no obligation to continue to publish NDX, and may discontinue publication of NDX at any time. NDX is determined, comprised and calculated by Nasdaq without
      regard to this instrument.</div>
    <div style="text-align: justify; margin-top: 6pt;">As discussed more fully in the underlier supplement under the heading &#8220;Indices &#8211; Nasdaq-100 Index<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup>&#8221;, NDX includes 100 of the largest domestic and international non-financial securities
      listed on the Nasdaq Stock Market<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> based on market capitalization. NDX includes companies across major industry groups including computer hardware and software, telecommunications, retail and wholesale trade, and biotechnology, but does
      not contain securities of financial companies, including investment companies.</div>
    <div style="text-align: justify; margin-top: 6pt;">NDX is calculated under a modified capitalization-weighted methodology. The methodology is expected to retain in general the economic attributes of capitalization-weighting while providing enhanced
      diversification. To accomplish this, Nasdaq will review the composition of NDX on a quarterly basis and adjust the weightings of components using a proprietary algorithm, if certain pre-established weight distribution requirements are not met.</div>
    <div style="text-align: justify; margin-top: 6pt; font-weight: bold;">Historical Information</div>
    <div style="text-align: justify; margin-top: 6pt;">The graph below illustrates the performance of NDX from October 16, 2015 through October 16, 2025. The dotted lines represent its Contingent Interest Barrier Value of 18,492.93, which is equal to
      75.00% of its Initial Value, and its Barrier Value of 14,794.344, which is equal to 60.00% of its Initial Value.</div>
    <div style="text-align: center; margin-top: 6pt; font-size: 10pt; font-weight: bold;">Nasdaq-100 Index<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> (NDX)</div>
    <div style="text-align: center; margin-bottom: 6pt;"><img src="image00003.jpg"></div>
    <div style="font-style: italic; font-weight: bold; text-align: center;">PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS.</div>
    <div style="font-style: italic; font-weight: bold;"> <br>
    </div>
    <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
      <div style="width: 100%;" class="BRPFPageFooter">
        <div>
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;">

              <tr>
                <td style="width: 50.00%;">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-size: 8pt;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50.00%;">
                  <div style="text-align: right; color: rgb(0, 0, 0); font-size: 8pt;">P-<font class="BRPFPageNumber">17</font></div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div style="width: 100%;" class="BRPFPageHeader"></div>
    </div>
    <div style="margin-bottom: 8pt; font-weight: bold;">
      <div>
        <table cellspacing="0" cellpadding="0" border="0" style="border-collapse: collapse; margin: 0px 0px 6pt; width: 5%; color: #000000; font-family: Arial; font-size: 9pt; text-align: left;">

            <tr>
              <td nowrap="nowrap" style="width: 5%; vertical-align: top; border-bottom: 1px solid rgb(0, 0, 0);"><font style="font-weight: bold;">Russell 2000<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index</font> </td>
            </tr>

        </table>
      </div>
    </div>
    <div style="text-align: justify; margin-top: 6pt;">We have derived all information regarding the Russell 2000<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index (&#8220;RTY&#8221;) contained in this document, including, without limitation, its make-up, method of calculation and changes in its
      components, from publicly available information. Such information reflects the policies of, and is subject to change by the Frank Russell Company (the &#8220;Index Sponsor&#8221; or &#8220;FTSE Russell&#8221;).</div>
    <div style="text-align: justify; margin-top: 6pt;">RTY is published by FTSE Russell, but FTSE Russell has no obligation to continue to publish RTY, and may discontinue publication of RTY at any time. RTY is determined, comprised and calculated by FTSE
      Russell without regard to this instrument.</div>
    <div style="text-align: justify; margin-top: 6pt;">As discussed more fully in the underlier supplement under the heading &#8220;Indices &#8211; The Russell 2000<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index,&#8221; RTY measures the composite price performance of the smallest 2,000 companies
      included in the Russell 3000<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index. The Russell 3000<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index is composed of the 3,000 largest United States companies by market capitalization and represents approximately 98% of the market capitalization of the United States
      equity market. Select information regarding top constituents and industry and/or sector weightings may be made available by the Index Sponsor on its website. RTY&#8217;s value is calculated by adding the market values of the underlying constituents and
      then dividing the derived total market capitalization by the &#8220;adjusted&#8221; capitalization of RTY on the base date of December 31, 1986.</div>
    <div style="text-align: justify; margin-top: 6pt; font-weight: bold;">Historical Information</div>
    <div style="text-align: justify; margin-top: 6pt;">The graph below illustrates the performance of RTY from October 16, 2015 through October 16, 2025. The dotted lines represent its Contingent Interest Barrier Value of 1,850.2613, which is equal to
      75.00% of its Initial Value, and its Barrier Value of 1,480.209, which is equal to 60.00% of its Initial Value.</div>
    <div style="text-align: center; margin-top: 6pt; font-size: 10pt; font-weight: bold;">Russell 2000<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index (RTY)</div>
    <div style="text-align: center; margin-bottom: 6pt;"><img src="image00001.jpg"></div>
    <div style="font-style: italic; font-weight: bold; text-align: center;">PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS.</div>
    <div style="font-style: normal; font-weight: 400;"> <br>
    </div>
    <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
      <div style="width: 100%;" class="BRPFPageFooter">
        <div>
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;">

              <tr>
                <td style="width: 50.00%;">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-size: 8pt;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50.00%;">
                  <div style="text-align: right; color: rgb(0, 0, 0); font-size: 8pt;">P-<font class="BRPFPageNumber">18</font></div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div style="width: 100%;" class="BRPFPageHeader"></div>
    </div>
    <div style="margin-bottom: 8pt; font-weight: bold;">
      <div>
        <table cellspacing="0" cellpadding="0" border="0" style="border-collapse: collapse; margin: 0px 0px 6pt; width: 5%; color: #000000; font-family: Arial; font-size: 9pt; text-align: left;">

            <tr>
              <td nowrap="nowrap" style="width: 5%; vertical-align: top; border-bottom: 1px solid rgb(0, 0, 0);"><font style="font-weight: bold;">S&amp;P 500<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index</font> </td>
            </tr>

        </table>
      </div>
    </div>
    <div style="text-align: justify; margin-top: 6pt; color: rgb(0, 0, 0);">We have derived all information regarding the S&amp;P 500<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index (&#8220;SPX&#8221;) contained in this document, including, without limitation, its make-up, method of calculation
      and changes in its components, from publicly available information. Such information reflects the policies of, and is subject to change by S&amp;P Dow Jones Indices LLC (its &#8220;Index Sponsor&#8221; or &#8220;S&amp;P Dow Jones&#8221;).</div>
    <div style="text-align: justify; margin-top: 6pt; color: rgb(0, 0, 0);">SPX is published by S&amp;P Dow Jones, but S&amp;P Dow Jones has no obligation to continue to publish SPX, and may discontinue publication of SPX at any time. SPX is determined,
      comprised and calculated by S&amp;P Dow Jones without regard to this instrument.</div>
    <div style="text-align: justify; margin-top: 6pt; color: rgb(0, 0, 0);">As discussed more fully in the underlier supplement under the heading &#8220;Indices &#8212; S&amp;P 500<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index&#8221;, SPX is intended to provide an indication of the pattern of common
      stock price movement. The calculation of the value of SPX is based on the relative value of the aggregate market value of the common stock of 500 companies as of a particular time compared to the aggregate average market value of the common stocks of
      500 similar companies during the base period of the years 1941 through 1943. Select information regarding top constituents and industry and/or sector weightings may be made available by the Index Sponsor on its website.</div>
    <div style="text-align: justify; margin-top: 6pt; font-weight: bold;">Historical Information</div>
    <div style="text-align: justify; margin-top: 6pt;">The graph below illustrates the performance of SPX from October 16, 2015 through October 16, 2025. The dotted lines represent its Contingent Interest Barrier Value of 4,971.8025, which is equal to
      75.00% of its Initial Value, and its Barrier Value of 3,977.442, which is equal to 60.00% of its Initial Value.</div>
    <div style="text-align: center; margin-top: 6pt; font-size: 10pt; font-weight: bold;">S&amp;P 500<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index (SPX)</div>
    <div style="text-align: center; margin-bottom: 6pt;"><img src="image00002.jpg"></div>
    <div style="font-style: italic; font-weight: bold; text-align: center;">PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS.</div>
    <div style="font-style: italic; font-weight: bold;"> <br>
    </div>
    <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
      <div style="width: 100%;" class="BRPFPageFooter">
        <div>
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;">

              <tr>
                <td style="width: 50.00%;">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-size: 8pt;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50.00%;">
                  <div style="text-align: right; color: rgb(0, 0, 0); font-size: 8pt;">P-<font class="BRPFPageNumber">19</font></div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div style="width: 100%;" class="BRPFPageHeader"></div>
    </div>
    <div style="margin-bottom: 8pt; color: rgb(0, 176, 80); font-size: 16pt;">Material U.S. Federal Income Tax Consequences</div>
    <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">The U.S. federal income tax consequences of your investment in the Notes are uncertain. No statutory, regulatory, judicial or administrative authority directly discusses the
      characterization for U.S. federal income tax purposes of securities with terms that are substantially the same as the Notes. Some of these tax consequences are summarized below, but we urge you to read the more detailed discussion under &#8220;Material
      U.S. Federal Income Tax Consequences&#8221; in the product supplement and to discuss the tax consequences of your particular situation with your tax advisor. This discussion is based upon the U.S. Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;),
      final, temporary and proposed U.S. Department of the Treasury (the &#8220;Treasury&#8221;) regulations, rulings and decisions, in each case, as available and in effect as of the date hereof, all of which are subject to change, possibly with retroactive effect.
      This discussion applies to you only if you are a U.S. holder, as defined in the product supplement. An investment in the Notes is not appropriate for non-U.S. holders and we will not attempt to ascertain the tax consequences to non-U.S. holders of
      the purchase, ownership or disposition of the Notes. Tax consequences under state, local and non-U.S. laws are not addressed herein. No ruling from the U.S. Internal Revenue Service (the &#8220;IRS&#8221;) has been sought as to the U.S. federal income tax
      consequences of your investment in the Notes, and the following discussion is not binding on the IRS.</div>
    <div style="text-align: justify; margin-bottom: 6pt;"><font style="font-style: italic;">U.S. Tax Treatment.</font> Pursuant to the terms of the Notes, TD and you agree, in the absence of a statutory or regulatory change or an administrative
      determination or judicial ruling to the contrary, to treat the Notes as prepaid derivative contracts with respect to the Reference Assets. If your Notes are so treated, any Contingent Interest Payments paid on the Notes (including any Contingent
      Interest Payments paid with respect to a Call Payment Date or on the Maturity Date) would be treated as ordinary income includable in income by you in accordance with your regular method of accounting for U.S. federal income tax purposes. Holders are
      urged to consult their tax advisors concerning the significance, and the potential impact, of the above considerations.</div>
    <div style="text-align: justify; margin-bottom: 6pt;">Upon the taxable disposition (including cash settlement) of a Note, you generally should recognize gain or loss equal to the difference between the amount realized on such taxable disposition
      (adjusted for amounts or proceeds attributable to any accrued and unpaid Contingent Interest Payments, which would be treated as ordinary income) and your tax basis in the Note. Your tax basis in a Note generally should equal your cost for the Note.
      Such gain or loss should generally be long-term capital gain or loss if you have held your Notes for more than one year (otherwise such gain or loss should be short-term capital gain or loss if held for one year or less).<font style="font-size: 8pt;">&#160;</font>The

      deductibility of capital losses is subject to limitations. Although uncertain, it is possible that proceeds received from the sale or exchange of your Notes prior to a Contingent Interest Payment Date, but that could be attributed to an expected
      Contingent Interest Payment, could be treated as ordinary income. You should consult your tax advisor regarding this risk.</div>
    <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Based on certain factual representations received from us, our special U.S. tax counsel, Fried, Frank, Harris, Shriver &amp; Jacobson LLP, is of the opinion that it would be
      reasonable to treat your Notes in the manner described above. However, because there is no authority that specifically addresses the tax treatment of the Notes, it is possible that your Notes could alternatively be treated for tax purposes as a
      single contingent payment debt instrument, or pursuant to some other characterization, such that the timing and character of your income from the Notes could differ materially and adversely from the treatment described above, as described further
      under &#8220;Material U.S. Federal Income Tax Consequences &#8211; Alternative Treatments&#8221; in the product supplement.</div>
    <div style="text-align: justify; margin-bottom: 6pt;">Except to the extent otherwise required by law, TD intends to treat your Notes for U.S. federal income tax purposes in accordance with the treatment described above and under &#8220;Material U.S. Federal
      Income Tax Consequences&#8221; in the product supplement, unless and until such time as the Treasury and the IRS determine that some other treatment is more appropriate.</div>
    <div style="text-align: justify; margin-bottom: 6pt;"><font style="font-style: italic;">Section 1297</font>. We will not attempt to ascertain whether any Reference Asset Constituent Issuer would be treated as a passive foreign investment company
      (&#8220;PFIC&#8221;) within the meaning of Section 1297 of the Code. If any such entity were so treated, certain adverse U.S. federal income tax consequences might apply upon the taxable disposition of a Note. You should refer to information filed with the SEC
      or the equivalent governmental authority by such entities and consult your tax advisors regarding the possible consequences to you if any such entity is or becomes a PFIC.</div>
    <div style="text-align: justify; margin-bottom: 6pt;"><font style="font-style: italic;">Notice 2008-2. </font>In 2007, the IRS released a notice that may affect the taxation of holders of the Notes. According to Notice 2008-2, the IRS and the Treasury
      are considering whether the holder of an instrument such as the Notes should be required to accrue ordinary income on a current basis. It is not possible to determine what guidance they will ultimately issue, if any. It is possible, however, that
      under such guidance, holders of the Notes will ultimately be required to accrue current income, possibly in excess of any Contingent Interest Payments received, and this could be applied on a retroactive basis. According to the Notice, the IRS and
      the Treasury are also considering other relevant issues, including whether additional gain or loss from such instruments should be treated as ordinary or capital and whether the special &#8220;constructive ownership rules&#8221; of Section 1260 of the Code
      should be applied to such instruments. You are urged to consult your tax advisor concerning the significance, and the potential impact, of the above considerations.</div>
    <div style="text-align: justify;"><font style="font-style: italic;">Medicare Tax on Net Investment Income. </font>U.S. holders that are individuals, estates or certain trusts are subject to an additional 3.8% tax on all or a portion of their &#8220;net
      investment income&#8221; or &#8220;undistributed net investment income&#8221; in the case of an estate or trust, which may include any income or gain realized with respect to the Notes, to the extent of their net investment income or undistributed net investment
      income (as the case may be) that when added to their other modified adjusted gross income, exceeds $200,000 for an unmarried individual, $250,000 for a married taxpayer filing a joint return (or a surviving spouse), $125,000 for a married individual
      filing a separate return or the dollar amount at which the highest tax bracket begins for an estate or trust. The 3.8% Medicare tax is determined in a different manner than the income tax. You should consult your tax advisor as to the consequences of
      the 3.8% Medicare tax.</div>
    <div style="text-align: justify;"> <br>
    </div>
    <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
      <div style="width: 100%;" class="BRPFPageFooter">
        <div>
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;">

              <tr>
                <td style="width: 50.00%;">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-size: 8pt;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50.00%;">
                  <div style="text-align: right; color: rgb(0, 0, 0); font-size: 8pt;">P-<font class="BRPFPageNumber">20</font></div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div style="width: 100%;" class="BRPFPageHeader"></div>
    </div>
    <div style="text-align: justify; margin-bottom: 6pt;"><font style="font-style: italic;">Specified Foreign Financial Assets. </font>U.S. holders may be subject to reporting obligations with respect to their Notes if they do not hold their Notes in an
      account maintained by a financial institution and the aggregate value of their Notes and certain other &#8220;specified foreign financial assets&#8221; (applying certain attribution rules) exceeds an applicable threshold. Significant penalties can apply if a
      U.S. holder is required to disclose its Notes and fails to do so.</div>
    <div style="text-align: justify; margin-bottom: 6pt;"><font style="font-style: italic;">Backup Withholding and Information Reporting.</font> The proceeds received from a taxable disposition of the Notes will be subject to information reporting unless
      you are an &#8220;exempt recipient&#8221; and may also be subject to backup withholding at the rate specified in the Code if you fail to provide certain identifying information (such as an accurate taxpayer number, if you are a U.S. holder) or meet certain other
      conditions.</div>
    <div style="text-align: justify; margin-bottom: 6pt;"><font style="font-style: italic;">Proposed Legislation. </font>In 2007, legislation was introduced in Congress that, if it had been enacted, would have required holders of Notes purchased after the
      bill was enacted to accrue interest income over the term of the Notes despite the fact that there may be no interest payments over the term of the Notes.</div>
    <div style="text-align: justify; margin-bottom: 6pt;">Furthermore, in 2013, the House Ways and Means Committee released in draft form certain proposed legislation relating to financial instruments. If it had been enacted, the effect of this legislation
      generally would have been to require instruments such as the Notes to be marked to market on an annual basis with all gains and losses to be treated as ordinary, subject to certain exceptions.</div>
    <div style="text-align: justify; margin-bottom: 6pt;">It is impossible to predict whether any similar or identical bills will be enacted in the future, or whether any such bill would affect the tax treatment of your Notes. You are urged to consult your
      tax advisor regarding the possible changes in law and their possible impact on the tax treatment of your Notes.</div>
    <div style="font-weight: bold; text-align: justify;">You are urged to consult your tax advisor concerning the application of U.S. federal income tax laws to an investment in the Notes, as well as any tax consequences of the purchase, beneficial
      ownership and disposition of the Notes arising under the laws of any state, local, non-U.S. or other taxing jurisdiction (including that of TD and those of the Reference Asset Constituent Issuers).</div>
    <div style="font-weight: bold; text-align: justify;"> <br>
    </div>
  </div>
  <div>
    <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
      <div style="width: 100%;" class="BRPFPageFooter">
        <div>
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;">

              <tr>
                <td style="width: 50.00%;">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-size: 8pt;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50.00%;">
                  <div style="text-align: right; color: rgb(0, 0, 0); font-size: 8pt;">P-<font class="BRPFPageNumber">21</font></div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div style="width: 100%;" class="BRPFPageHeader"></div>
    </div>
    <div style="text-align: justify; margin-top: 6pt; color: rgb(0, 176, 80); font-size: 16pt;">Supplemental Plan of Distribution (Conflicts of Interest)</div>
    <div style="text-align: justify; margin-top: 6pt; margin-bottom: 6pt;">We have appointed TDS, an affiliate of TD, as the Agent for the sale of the Notes. Pursuant to the terms of a distribution agreement, TDS will purchase the Notes from TD at the
      public offering price less the underwriting discount specified on the cover page hereof and will use all of that commission to allow selling concessions to other registered broker-dealers in connection with the distribution of the Notes. The
      underwriting discount represents the selling concessions for other dealers in connection with the distribution of the Notes. TD will also periodically pay one or more unaffiliated dealers a structuring fee and/or marketing fee per Note in the amount
      indicated on the cover hereof with respect to all of the Notes. We or one of our affiliates will also pay a fee to iCapital Markets LLC, who is acting as a dealer in connection with the distribution of the Notes. TD will reimburse TDS for certain
      expenses in connection with its role in the offer and sale of the Notes, and TD will pay TDS a fee in connection with its role in the offer and sale of the Notes.</div>
    <div style="text-align: justify; margin-bottom: 6pt;"><font style="font-style: italic;">Conflicts of Interest. </font>TDS is an affiliate of TD and, as such, has a &#8216;&#8216;conflict of interest&#8217;&#8217; in this offering within the meaning of Financial Industry
      Regulatory Authority, Inc. (&#8220;FINRA&#8221;) Rule 5121. If any other affiliate of TD participates in this offering, that affiliate will also have a &#8220;conflict of interest&#8221; within the meaning of FINRA Rule 5121. In addition, TD will receive the net proceeds
      from the initial public offering of the Notes, thus creating an additional conflict of interest within the meaning of FINRA Rule 5121. This offering of the Notes will be conducted in compliance with the provisions of FINRA Rule 5121. In accordance
      with FINRA Rule 5121, neither TDS nor any other affiliate of ours is permitted to sell the Notes in this offering to an account over which it exercises discretionary authority without the prior specific written approval of the account holder.</div>
    <div style="text-align: justify; margin-bottom: 6pt;">We, TDS, another of our affiliates or third parties may use this pricing supplement in the initial sale of the Notes. In addition, we, TDS, another of our affiliates or third parties may use this
      pricing supplement in a market-making transaction in the Notes after their initial sale. <font style="font-weight: bold; font-style: italic;">If a purchaser buys the Notes from us, TDS, another of our affiliates or third parties, this pricing
        supplement is being used in a market-making transaction unless we, TDS, another of our affiliates or third parties informs such purchaser otherwise in the confirmation of sale.</font></div>
    <div style="text-align: justify; margin-top: 3pt; font-weight: bold;">Prohibition on Sales to EEA Retail Investors</div>
    <div style="text-align: justify; margin-top: 3pt;">The Notes are not intended to be offered, sold or otherwise made available to and should not be offered, sold or otherwise made available to any retail investor in the European Economic Area (the
      &#8220;EEA&#8221;). For these purposes, a retail investor means a person who is one (or more) of: (i) a retail client as defined in point (11) of Article 4(1) of Directive 2014/65/EU (as amended, &#8220;MiFID II&#8221;); (ii) a customer within the meaning of Directive (EU)
      2016/97, where that customer would not qualify as a professional client as defined in point (10) of Article 4(1) of MiFID II; or (iii) not a qualified investor as defined in Regulation (EU) 2017/1129, as amended. Consequently no key information
      document required by Regulation (EU) No 1286/2014 (the &#8220;EU PRIIPs Regulation&#8221;) for offering or selling the Notes or otherwise making them available to retail investors in the EEA has been prepared and therefore offering or selling the Notes or
      otherwise making them available to any retail investor in the EEA may be unlawful under the EU PRIIPs Regulation.</div>
    <div style="text-align: justify; margin-top: 3pt; font-weight: bold;">Prohibition on Sales to United Kingdom Retail Investors</div>
    <div style="text-align: justify; margin-top: 3pt;">The Notes are not intended to be offered, sold or otherwise made available to and should not be offered, sold or otherwise made available to any retail investor in the United Kingdom (&#8220;UK&#8221;). For these
      purposes, a retail investor means a person who is one (or more) of: (i) a retail client, as defined in point (8) of Article 2 of Regulation (EU) No 2017/565 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018 (the
      &#8220;EUWA&#8221;); or (ii) a customer within the meaning of the provisions of the Financial Services and Markets Act 2000 (the &#8220;FSMA&#8221;) and any rules or regulations made under the FSMA to implement Directive (EU) 2016/97, where that customer would not qualify
      as a professional client, as defined in point (8) of Article 2(1) of Regulation (EU) No 600/2014 as it forms part of domestic law by virtue of the EUWA. Consequently no key information document required by Regulation (EU) No 1286/2014 as it forms
      part of domestic law by virtue of the EUWA (the &#8220;UK PRIIPs Regulation&#8221;) for offering or selling the Notes or otherwise making them available to retail investors in the UK has been prepared and therefore offering or selling the Notes or otherwise
      making them available to any retail investor in the UK may be unlawful under the UK PRIIPs Regulation.</div>
    <div style="text-align: justify;"> <br>
    </div>
    <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
      <div style="width: 100%;" class="BRPFPageFooter">
        <div>
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;">

              <tr>
                <td style="width: 50.00%;">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-size: 8pt;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50.00%;">
                  <div style="text-align: right; color: rgb(0, 0, 0); font-size: 8pt;">P-<font class="BRPFPageNumber">22</font></div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div style="width: 100%;" class="BRPFPageHeader"></div>
    </div>
    <div style="text-align: justify; margin-top: 3pt; color: rgb(0, 176, 80); font-size: 16pt;">Additional Information Regarding the Estimated Value of the Notes</div>
    <div style="text-align: justify; margin-top: 6pt; margin-bottom: 6pt;">The final terms for the Notes were determined on the Pricing Date, based on prevailing market conditions, and are specified elsewhere in this pricing supplement.</div>
    <div style="text-align: justify; margin-bottom: 6pt;">The economic terms of the Notes are based on our internal funding rate (which is our internal borrowing rate based on variables such as market benchmarks and our appetite for borrowing), and several
      factors, including any sales commissions expected to be paid to TDS or another affiliate of ours, any selling concessions, discounts, commissions or fees expected to be allowed or paid to non-affiliated intermediaries, the estimated profit that we or
      any of our affiliates expect to earn in connection with structuring the Notes, estimated costs which we may incur in connection with the Notes and the estimated cost which we may incur in hedging our obligations under the Notes. Because our internal
      funding rate generally represents a discount from the levels at which our benchmark debt securities trade in the secondary market, the use of an internal funding rate for the Notes rather than the levels at which our benchmark debt securities trade
      in the secondary market is expected to have had an adverse effect on the economic terms of the Notes.</div>
    <div style="text-align: justify; margin-bottom: 6pt;">On the cover page of this pricing supplement, we have provided the estimated value for the Notes. The estimated value was determined by reference to our internal pricing models which take into
      account a number of variables and are based on a number of assumptions, which may or may not materialize, typically including volatility, interest rates (forecasted, current and historical rates), price-sensitivity analysis, time to maturity of the
      Notes and our internal funding rate. For more information about the estimated value, see &#8220;Additional Risk Factors &#8212; Risks Relating to Estimated Value and Liquidity&#8221; herein. Because our internal funding rate generally represents a discount from the
      levels at which our benchmark debt securities trade in the secondary market, the use of an internal funding rate for the Notes rather than the levels at which our benchmark debt securities trade in the secondary market is expected, assuming all other
      economic terms are held constant, to increase the estimated value of the Notes. For more information see the discussion under &#8220;Additional Risk Factors &#8212; Risks Relating to Estimated Value and Liquidity &#8212; The Estimated Value of Your Notes Is Based on
      Our Internal Funding Rate.&#8221;</div>
    <div style="text-align: justify; margin-bottom: 6pt;">Our estimated value of the Notes is not a prediction of the price at which the Notes may trade in the secondary market, nor will it be the price at which the Agent may buy or sell the Notes in the
      secondary market. Subject to normal market and funding conditions, the Agent or another affiliate of ours intends to offer to purchase the Notes in the secondary market but it is not obligated to do so.</div>
    <div style="text-align: justify; margin-bottom: 6pt;">Assuming that all relevant factors remain constant after the Pricing Date, the price at which the Agent may initially buy or sell the Notes in the secondary market, if any, may exceed our estimated
      value on the Pricing Date for a temporary period expected to be approximately 3 months after the Issue Date because, in our discretion, we may elect to effectively reimburse to investors a portion of the estimated cost of hedging our obligations
      under the Notes and other costs in connection with the Notes which we will no longer expect to incur over the term of the Notes. We made such discretionary election and determined this temporary reimbursement period on the basis of a number of
      factors, including the tenor of the Notes and any agreement we may have with the distributors of the Notes. The amount of our estimated costs which we effectively reimburse to investors in this way may not be allocated ratably throughout the
      reimbursement period, and we may discontinue such reimbursement at any time or revise the duration of the reimbursement period after the Issue Date of the Notes based on changes in market conditions and other factors that cannot be predicted.</div>
    <div style="margin: 12pt 0px 0px; font-weight: bold; text-align: justify;">We urge you to read the &#8220;Additional Risk Factors&#8221; herein.</div>
    <div style="margin: 0px 0px; font-weight: bold; text-align: justify;"> <br>
    </div>
    <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
      <div style="width: 100%;" class="BRPFPageFooter">
        <div>
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;">

              <tr>
                <td style="width: 50.00%;">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-size: 8pt;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50.00%;">
                  <div style="text-align: right; color: rgb(0, 0, 0); font-size: 8pt;">P-<font class="BRPFPageNumber">23</font></div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div style="width: 100%;" class="BRPFPageHeader"></div>
    </div>
    <div style="margin-bottom: 6pt; color: rgb(0, 176, 80); font-size: 16pt;">Validity of the Notes</div>
    <div style="text-align: justify; margin-top: 12pt; margin-bottom: 6pt;">In the opinion of Fried, Frank, Harris, Shriver &amp; Jacobson LLP, as special products counsel to TD, when the Notes offered by this pricing supplement have been executed and
      issued by TD and authenticated by the trustee pursuant to the indenture and delivered, paid for and sold as contemplated herein, the Notes will be valid and binding obligations of TD, enforceable against TD in accordance with their terms, subject to
      applicable bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium, receivership or other laws relating to or affecting creditors&#8217; rights generally, and to general principles of equity (regardless of whether enforcement is sought in
      a proceeding at law or in equity). This opinion is given as of the date hereof and is limited to the laws of the State of New York. Insofar as this opinion involves matters governed by Canadian law, Fried, Frank, Harris, Shriver &amp; Jacobson LLP
      has assumed, without independent inquiry or investigation, the validity of the matters opined on by McCarthy T&#233;trault LLP, Canadian legal counsel for TD, in its opinion expressed below. In addition, this opinion is subject to customary assumptions
      about the trustee&#8217;s authorization, execution and delivery of the indenture and, with respect to the Notes, authentication of the Notes and the genuineness of signatures and certain factual matters, all as stated in the opinion of Fried, Frank,
      Harris, Shriver &amp; Jacobson LLP filed as Exhibit 5.3 to the registration statement on Form F-3 filed by TD on December 20, 2024.</div>
    <div style="margin: 12pt 0px 0px; text-align: justify;">In the opinion of McCarthy T&#233;trault LLP, the issue and sale of the Notes has been duly authorized by all necessary corporate action on the part of TD, and when this pricing supplement has been
      attached to, and duly notated on, the master note that represents the Notes, the Notes will have been validly executed and issued and, to the extent validity of the Notes is a matter governed by the laws of the Province of Ontario, or the laws of
      Canada applicable therein, will be valid obligations of TD, subject to the following limitations: (i) the enforceability of the indenture is subject to bankruptcy, insolvency, reorganization, arrangement, winding up, moratorium and other similar laws
      of general application limiting the enforcement of creditors&#8217; rights generally; (ii) the enforceability of the indenture is subject to general equitable principles, including the fact that the availability of equitable remedies, such as injunctive
      relief and specific performance, is in the discretion of a court; (iii) courts in Canada are precluded from giving a judgment in any currency other than the lawful money of Canada; and (iv) the enforceability of the indenture will be subject to the
      limitations contained in the Limitations Act, 2002 (Ontario), and such counsel expresses no opinion as to whether a court may find any provision of the indenture to be unenforceable as an attempt to vary or exclude a limitation period under that Act.
      This opinion is given as of the date hereof and is limited to the laws of the Province of Ontario and the federal laws of Canada applicable thereto. In addition, this opinion is subject to: (i) the assumption that the senior indenture has been duly
      authorized, executed and delivered by, and constitutes a valid and legally binding obligation of, the trustee, enforceable against the trustee in accordance with its terms; and (ii) customary assumptions about the genuineness of signatures and
      certain factual matters all as stated in the letter of such counsel dated December 20, 2024, which has been filed as Exhibit 5.2 to the registration statement on Form F-3 filed by TD on December 20, 2024.</div>
    <div style="margin: 0px 0px; text-align: justify;"> <br>
    </div>
    <div style="margin: 0px 0px; text-align: justify;"> <br>
    </div>
    <div style="margin: 0px 0px; text-align: justify;">
      <div style="width: 100%;" class="BRPFPageFooter">
        <div>
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;">

              <tr>
                <td style="width: 50.00%;">
                  <div style="text-align: left; color: rgb(0, 0, 0); font-size: 8pt;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50.00%;">
                  <div style="text-align: right; color: rgb(0, 0, 0); font-size: 8pt;">P-<font class="BRPFPageNumber">24</font></div>
                </td>
              </tr>

          </table>
        </div>
      </div>
    </div>
    <div style="margin: 0px 0px; text-align: justify;">
      <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"> </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>2
<FILENAME>exfilingfees.htm
<DESCRIPTION>EXHIBIT 107.1
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Fri Oct 17 15:05:42 UTC 2025 -->
<!--?xml version="1.0" encoding="ASCII"?-->
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Tue Mar 04 23:02:01 UTC 2025 -->
<html xmlns:compsci="http://compsciresources.com" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:ffd="http://xbrl.sec.gov/ffd/2025" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:us-types="http://fasb.org/us-types/2025" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.w3.org/1999/xhtml">
  <head>
    <title> </title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc. Document created using Broadridge PROfile 25.1.1.5279 Copyright 1995 - 2025 Broadridge -->



<meta content="text/html" http-equiv="Content-Type"/>
</head>
<body><div style="font-family: Arial; font-size: 9pt; text-align: left; color: rgb(0, 0, 0);"><div>
    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: medium; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; padding-bottom: 20px;">

      <div>
        <div style="text-align: center; font-family: Arial; font-size: 20pt; font-weight: bold;">Calculation of Filing Fee Tables</div>
        <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 12pt; font-weight: bold;"><span style="font-size: 10pt;">&#160; </span><br/>
        </div>
        <div style="text-align: center; font-family: Arial; font-size: 20pt; font-weight: bold;"><ix:nonNumeric contextRef="c0" name="ffd:FormTp" id="ixv-32">F-3</ix:nonNumeric></div>
        <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 12pt; font-weight: bold;"><span style="font-size: 10pt;">&#160; </span><br/>
        </div>
        <div style="text-align: center; font-family: Arial; font-size: 20pt; font-weight: bold;"><ix:nonNumeric contextRef="c0" name="dei:EntityRegistrantName" id="ixv-33">TORONTO DOMINION BANK</ix:nonNumeric></div>
        <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 12pt; font-weight: bold;"><span style="font-size: 10pt;">&#160; </span><br/>
        </div>
        <div style="text-align: center; font-family: Arial; font-size: 12pt; font-weight: bold;">Narrative Disclosure</div>
        <div style="text-align: center; font-family: 'Times New Roman',serif; font-size: 12pt;"><span style="font-size: 10pt;">&#160; </span><br/>
        </div>

        <ix:nonNumeric contextRef="c0" escape="true" name="ffd:NrrtvDsclsr" id="ixv-26"><div style="text-align: center; font-family: Arial; font-size: 12pt;">The maximum aggregate offering price of the securities to which the prospectus relates is <span style="text-decoration-thickness: initial; float: none; display: inline !important;">$<ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="ffd:NrrtvMaxAggtOfferingPric" scale="0" unitRef="usd" id="ixv-34">1,091,000.00</ix:nonFraction></span>. The prospectus is a <ix:nonNumeric contextRef="c0" format="ixt:fixed-true" name="ffd:FnlPrspctsFlg" id="ixv-35">final prospectus</ix:nonNumeric> for the related offering.</div></ix:nonNumeric><div><br/>
        </div>
      </div>
    </div>
  </div></div><div style="display: none"><ix:header>
<ix:hidden>
<ix:nonNumeric contextRef="c0" name="ffd:CombinedProspectusTableNa" id="ixv-38">N/A</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="dei:EntityCentralIndexKey" id="ixv-39">0000947263</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="ffd:FeeExhibitTp" id="ixv-40">EX-FILING FEES</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="ffd:OfferingTableNa" id="ixv-41">N/A</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="ffd:OffsetTableNa" id="ixv-42">N/A</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="ffd:RegnFileNb" id="ixv-43">333-283969</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="ffd:SubmissnTp" id="ixv-44">424B2</ix:nonNumeric>
</ix:hidden>
<ix:references><link:schemaRef xlink:href="https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd" xlink:type="simple"/></ix:references>
<!-- [WMV6][Y3Dfa4648xWXXeCi48k1zK7Vt3au3DxX0rQ1UPo1jl7q5wY/zkc3K9kFainsJL50xE0mqaEhn+Z5gYlBdciSG9nELknyhbTKL2ImWpaoc52Gq4LSnonuEnUIaXFg2Sbe20j1rapOIiSgBtzXZ1tNOjshTPBJDonFsqosFrPtMt7hHvZSLzDz6r4V4eqmAtziYrbYvYipT2D2+2znxW6a6NT45MhkZwmBxRcyKyowaZciJeG4Y/+9gLabR/BQ7ISyzrMg4S4cRxZdcZbJcj7UYSCEXB/9xPQ8zCKNmqZ7aMImcOv3Q69mHAOC3wD5XB3zK4QDq9r89QZFyyw77hNRRgHD69X7Bm83aO6W8kR9pAUfc+SJhT9hlU3JDBwMXFjVG9SKq9wP2dIhw9h4/4HmQY17mItwsNSqG72et0/HSVe6vY19f/Uvi5hmfMEujHL3N2PpSxpoloZOQE/piZxeIrfeLVro3EZ4kTI=] CSR-->
<ix:resources xmlns="http://www.xbrl.org/2003/instance"><xbrli:context xmlns="" id="c0">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000947263</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-10-16</xbrli:startDate>
    <xbrli:endDate>2025-10-16</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:unit xmlns="" id="usd">
  <xbrli:measure>iso4217:USD</xbrli:measure>
</xbrli:unit></ix:resources></ix:header>

</div></body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image0.jpg
<TEXT>
begin 644 image0.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !) %$# 2(  A$! Q$!_\0
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MVO/^C5OVD/\ PQWQ._\ F7KL_L+//^A-FO\ X;L7_P#*3U_]2.-/^B0XH_\
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M_%.'_J\O_G//_P >3_-_HK_2 HH_XEG_ .JV_P#-;_\ P\'_ !3A_P"KR_\
(G//_ ,>3_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image00001.jpg
<TEXT>
begin 644 image00001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" %_ C<# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#ZIHHK'O-:
M%IJ45K)8WOE22K"+O">5O89 ^]O/U"D>_!P ;%%9>JZM]AFA@BLKJ^N959Q#
M;;,A5P"Q+LH RR]\\].M9\GBRV^SK/:V5_>0BW%U,T")^X0Y^\&8'/RM\JAC
MQTZ9 .DHKG[7Q/;75U L=K=_8[B5H(+XA/)E<9X'S;OX2 2H!(X/(ST% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !-&F_\ )4_$/_8%TS_T??UU5 '*_P#"N/!'_0F^&_\ P5P?_$T?\*X\$?\
M0F^&_P#P5P?_ !-=510!RO\ PKCP1_T)OAO_ ,%<'_Q-'_"N/!'_ $)OAO\
M\%<'_P 37544 <K_ ,*X\$?]";X;_P#!7!_\31_PKCP1_P!";X;_ /!7!_\
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MKCP1_P!";X;_ /!7!_\ $UU5% '*_P#"N/!'_0F^&_\ P5P?_$T?\*X\$?\
M0F^&_P#P5P?_ !-=510!RO\ PKCP1_T)OAO_ ,%<'_Q-'_"N/!'_ $)OAO\
M\%<'_P 37544 <K_ ,*X\$?]";X;_P#!7!_\31_PKCP1_P!";X;_ /!7!_\
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MKCP1_P!";X;_ /!7!_\ $UU5% '*_P#"N/!'_0F^&_\ P5P?_$T?\*X\$?\
M0F^&_P#P5P?_ !-=510!RO\ PKCP1_T)OAO_ ,%<'_Q-'_"N/!'_ $)OAO\
M\%<'_P 37544 <K_ ,*X\$?]";X;_P#!7!_\31_PKCP1_P!";X;_ /!7!_\
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MKCP1_P!";X;_ /!7!_\ $UU5% '*_P#"N/!'_0F^&_\ P5P?_$T?\*X\$?\
M0F^&_P#P5P?_ !-=510!RO\ PKCP1_T)OAO_ ,%<'_Q-'_"N/!'_ $)OAO\
M\%<'_P 37544 <K_ ,*X\$?]";X;_P#!7!_\36;X3T72]!^)'B.UT33;'3;9
MM)TZ1H;.W6%&?SKT%B% &< #/L*[RN5T[_DJ?B'_ + NF_\ H^^H ZJBBB@
MHHHH **** "BBB@ HHHH Y73?^2I^(?^P+IG_H^_KJJY73?^2I^(?^P+IG_H
M^_KJJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M% '*_P#"+ZO_ -#WXD_[\:?_ /(M'_"+ZO\ ]#WXD_[\:?\ _(M=510!RO\
MPB^K_P#0]^)/^_&G_P#R+1_PB^K_ /0]^)/^_&G_ /R+7544 <K_ ,(OJ_\
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M% '*_P#"+ZO_ -#WXD_[\:?_ /(M'_"+ZO\ ]#WXD_[\:?\ _(M=510!RO\
MPB^K_P#0]^)/^_&G_P#R+1_PB^K_ /0]^)/^_&G_ /R+7544 <K_ ,(OJ_\
MT/?B3_OQI_\ \BT?\(OJ_P#T/?B3_OQI_P#\BUU5% '*_P#"+ZO_ -#WXD_[
M\:?_ /(M'_"+ZO\ ]#WXD_[\:?\ _(M=510!RO\ PB^K_P#0]^)/^_&G_P#R
M+1_PB^K_ /0]^)/^_&G_ /R+7544 <I_PB^K_P#0]^)/^_&G?_(M'_"+ZO\
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M*** "BBB@ HHHH Y73?^2I^(?^P+IG_H^_KJJY73?^2I^(?^P+IG_H^_KJJ
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M")XD_P"_^G__ "51_P )1J__ $(GB3_O_I__ ,E5U5% '*_\)1J__0B>)/\
MO_I__P E4?\ "4:O_P!")XD_[_Z?_P#)5=510!RO_"4:O_T(GB3_ +_Z?_\
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M1Y^G]68L?^7KU)J;_A*-7_Z$3Q)_W_T__P"2JZJBLC9:'*?\)1J__0B>)/\
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M=)GOO'FFN2%M4A6<DG[S1.>/_(B^W)JCH6L6^H3^']*:(%[3R7^8@AO]&<Y
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M5%#VG+H3;#RDH.IJ]]-BEIWBG1;'6%LH-9TUO"T<JS"_:[0Q;@G4RYV\R?\
MCW%='I'C/P-IJ7*Q>,O#C-<7$EP[?VE .6;/]_L,#\*?XA\#/K5YI<C:]K%L
MMC T.^WN-DCDX&\D+U(SD_3CK5C7/!C:L+,'Q%K]I]GA$.;6[\OS<?QOA>6/
MK15K2GLO^"%+#4HVO/OTV)?^%B^"?^AQ\-G_ +BD'_Q5+_PL7P2>GC'PW_X-
M(/\ XJH=<\%MJPLP?$6OVGV:$19M;OR_-Q_&^%Y8^M&N>"VU868/B+7[3[/"
M(LVMV(_-Q_&^%Y8^M8WEV-8TZ3M>?X$W_"Q?!/\ T./AL_\ <4@_^*H_X6+X
M)/3QCX;_ /!I!_\ %5#KG@MM6%F#XBU^T^S0B+-K=^7YN/XWPO+'UHUSP6VK
M"S!\1:_:?9X1%FUNQ'YN/XWPO+'UHO+L$:=)VO/\";_A8O@G_H<?#9_[BD'_
M ,51_P +%\$GIXQ\-_\ @T@_^*J'7/!;:L+,'Q%K]I]FA$6;6[\OS<?QOA>6
M/K1KG@MM6%F#XBU^T^SPB+-K=B/S<?QOA>6/K1>78(TZ3M>?X$W_  L7P3_T
M./AL_P#<4@_^*H_X6+X)/3QCX;_\&D'_ ,54.N>"VU868/B+7[3[-"(LVMWY
M?FX_C?"\L?6C7/!;:L+,'Q%K]I]GA$6;6[$?FX_C?"\L?6B\NP1ITG:\_P "
M7_A8O@G_ *''PV?^XI!_\52_\+%\$GIXQ\-_^#2#_P"*J'7/!;:L+,'Q%K]I
M]FA$6;6[\OS<?QOA>6/K1KG@MM6%F#XBU^T^SPB+-K=B/S<?QOA>6/K1>78(
MTZ3M>?X$W_"Q?!/_ $./AL_]Q2#_ .*H_P"%B^"3T\8^&_\ P:0?_%5#KG@M
MM6%F#XBU^T^S0B+-K=^7YN/XWPO+'UHUSP6VK"S!\1:_:?9X1%FUNQ'YN/XW
MPO+'UHO+L$:=)VO/\"7_ (6+X)_Z''PV?^XI!_\ %4O_  L7P2>GC'PW_P"#
M2#_XJH=<\%MJPLP?$6OVGV:$19M;OR_-Q_&^%Y8^M&N>"VU868/B+7[3[/"(
MLVMV(_-Q_&^%Y8^M%Y=@C3I.UY_@2_\ "Q?!/_0X^&S_ -Q2#_XJE_X6+X)/
M3QCX;_\ !I!_\54.N>"VU868/B+7[3[-"(LVMWY?FX_C?"\L?6C7/!;:L+,'
MQ%K]I]GA$6;6[$?FX_C?"\L?6B\NP1ITG:\_P)O^%B^"?^AQ\-G_ +BD'_Q5
M'_"Q?!)Z>,?#?_@T@_\ BJAUSP6VK"S!\1:_:?9H1%FUN_+\W'\;X7ECZT:Y
MX+;5A9@^(M?M/L\(BS:W8C\W'\;X7ECZT7EV!4Z3M>?X$W_"Q?!/_0X^&S_W
M%(/_ (JC_A8O@D]/&/AO_P &D'_Q50ZYX+;5A9@^(M?M/LT(BS:W?E^;C^-\
M+RQ]:-<\%MJPLP?$6OVGV>$19M;L1^;C^-\+RQ]:+R[!&G2=KS_ F_X6+X)_
MZ''PV?\ N*0?_%4?\+%\$GIXQ\-_^#2#_P"*J'7/!;:L+,'Q%K]I]FA$6;6[
M\OS<?QOA>6/K1KG@MM6%F#XBU^T^SPB+-K=B/S<?QOA>6/K1>78(TZ3M>?X$
MW_"Q?!/_ $./AL_]Q2#_ .*H_P"%B^"3T\8^&_\ P:0?_%5#KG@MM6%F#XBU
M^T^S0B+-K=^7YN/XWPO+'UHUSP6VK"S!\1:_:?9X1%FUNQ'YN/XWPO+'UHO+
ML$:=)VO/\";_ (6+X)_Z''PV?^XI!_\ %4?\+%\$GIXQ\-_^#2#_ .*J'7/!
M;:L+,'Q%K]I]FA$6;6[\OS<?QOA>6/K1KG@MM6%F#XBU^T^SPB+-K=B/S<?Q
MOA>6/K1>78(TZ3M>?X$W_"Q?!/\ T./AL_\ <4@_^*H_X6+X)/3QCX;_ /!I
M!_\ %5#KG@MM6%F#XBU^T^S0B+-K=^7YN/XWPO+'UHUSP6VK"S!\1:_:?9X1
M%FUNQ'YN/XWPO+'UHO+L$:=)VO/\"4?$7P3S_P 5CX;_ /!I!_\ %5G>%-:T
MO7?B1XCN=$U*RU*V32=.C::SG69 PFO25)4D9P0<>XJYKG@MM6%D#XBU^T^S
M0B'-K=^7YN/XWPO+'UIN@PFU^(>L6ID>8PZ)IH\Z4YD?][>C+'N>,_B::;OJ
MB)0@HIQE=G944451D%%%% !1110 4444 %%%% '*Z;_R5/Q#_P!@73/_ $??
MUU5<KIO_ "5/Q#_V!=,_]'W]=50 4444 %%%,D=8T+.P55&22< 4 +BN.\0:
M]JT>J7%IH%NEZ$@0NRX;R7+LIS[].#Z$^M=>CJX)4@C)&1['FL/P;8Q6^DI>
M*6:YU!5NIW;'+L,G'MDG K2FXQO*2N95$Y6C%V.?FGUCQ/<RO;6L]C%9QF2V
M,GR[K@,ORD9P<%9%]!GGFDL-4U779(M'U6REMR9&,EU#\O\ JNZGID2!>1D5
MZ!0*OVRM;E]"/8.]^;U./T[09M80MXIBCN%A AMQN=6^5F#.WNWRGCK@5)XG
MTB[DOK)](5(O/B>PN&"GY(6&0P'0;<''N0*ZRBH]K*]R_8QM8BM8([:WC@A4
M)%$@1%[  8%3445F:I6"BBB@ HHHH *R/$[K%I:N[!%6ZMB68X 'GI6O6)XT
MMENO"NIQOGB!I!CU7YA^H%5"W,KD5/A=B;PSSH-G+_%<1_:'QTW2?.V/;+&M
M6HXHUBB1(U"(HPJJ, "I*4G=W'%65@HHHI%!1110 5E:(<2ZE'G_ %=VW'IN
M"M_[-6K65I/&H:WC_G[7_P!$14ULT3+='.>)H[?7]4TCR=TI@>1C&.3A;B*-
MB1_=QO/X>U=!X?T&TT2WV6J_OG1%EEY'F%1@'&<#O^=<?\(Y))9]9>4G<QB;
M![9+G^I->CBNC$.5-^QOHCGH*-3][;5BT445S'4%%%% !1110 4444 %%%%
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MD51DA?FP?QVM^5<Y<:/J/B)9O[:8V4"AT@M8R&!)'RR,0>2,_=]JQ]3T^[U
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M[\:?_P#(M '545RO_"+ZO_T/?B3_ +\:?_\ (M'_  B^K_\ 0]^)/^_&G_\
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M()Z9Y.2>,:4ZG(V_(SJ0Y[([.BN5_P"$7U?_ *'OQ)_WXT__ .1:/^$7U?\
MZ'OQ)_WXT_\ ^1:S-#JJ*Y7_ (1?5_\ H>_$G_?C3_\ Y%H_X1?5_P#H>_$G
M_?C3_P#Y%H ZJBN5_P"$7U?_ *'OQ)_WXT__ .1:/^$7U?\ Z'OQ)_WXT_\
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M_?C3_P#Y%H ZJBN5_P"$7U?_ *'OQ)_WXT__ .1:/^$7U?\ Z'OQ)_WXT_\
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M** "BBB@ HHHH **** "BBB@#E=-_P"2I^(?^P+IG_H^_KJJY73?^2I^(?\
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M *%[PU_X/I__ )#H ZJBN5^W>./^A>\-?^#Z?_Y#H^W>./\ H7O#7_@^G_\
MD.@#JJ*Y7[=XX_Z%[PU_X/I__D.C[=XX_P"A>\-?^#Z?_P"0Z .JHKE?MWCC
M_H7O#7_@^G_^0Z/MWCC_ *%[PU_X/I__ )#H ZJBN5^W>./^A>\-?^#Z?_Y#
MH^W>./\ H7O#7_@^G_\ D.@#JJ*Y7[=XX_Z%[PU_X/I__D.C[=XX_P"A>\-?
M^#Z?_P"0Z .JHKE?MWCC_H7O#7_@^G_^0Z/MWCC_ *%[PU_X/I__ )#H ZJB
MN5^W>./^A>\-?^#Z?_Y#H^W>./\ H7O#7_@^G_\ D.@#JJ*Y7[=XX_Z%[PU_
MX/I__D.C[=XX_P"A>\-?^#Z?_P"0Z .JHKE?MWCC_H7O#7_@^G_^0Z/MWCC_
M *%[PU_X/I__ )#H ZJBN5^W>./^A>\-?^#Z?_Y#H^W>./\ H7O#7_@^G_\
MD.@#JJ*Y7[=XX_Z%[PU_X/I__D.C[=XX_P"A>\-?^#Z?_P"0Z .JHKE?MWCC
M_H7O#7_@^G_^0Z/MWCC_ *%[PU_X/I__ )#H ZJBN5^W>./^A>\-?^#Z?_Y#
MH^W>./\ H7O#7_@^G_\ D.@#JJ*Y7[=XX_Z%[PU_X/I__D.C[=XX_P"A>\-?
M^#Z?_P"0Z .JHKE?MWCC_H7O#7_@^G_^0Z/MWCC_ *%[PU_X/I__ )#H ZJB
MN5^W>./^A>\-?^#Z?_Y#H^W>./\ H7O#7_@^G_\ D.@#JJ*Y7[=XX_Z%[PU_
MX/I__D.C[=XX_P"A>\-?^#Z?_P"0Z .JHKE?MWCC_H7O#7_@^G_^0Z/MWCC_
M *%[PU_X/I__ )#H ZJBN5^W>./^A>\-?^#Z?_Y#H^W>./\ H7O#7_@^G_\
MD.@#JJ*Y7[=XX_Z%[PU_X/I__D.C[=XX_P"A>\-?^#Z?_P"0Z .JHKE?MWCC
M_H7O#7_@^G_^0Z/MWCC_ *%[PU_X/I__ )#H ZJBN5^W>./^A>\-?^#Z?_Y#
MH^W>./\ H7O#7_@^G_\ D.@#JJ*Y7[=XX_Z%[PU_X/I__D.C[=XX_P"A>\-?
M^#Z?_P"0Z .JHKE?MWCC_H7O#7_@^G_^0Z/MWCC_ *%[PU_X/I__ )#H ZJB
MN5^W>./^A>\-?^#Z?_Y#H^W>./\ H7O#7_@^G_\ D.@#JJ*Y7[=XX_Z%[PU_
MX/I__D.C[=XX_P"A>\-?^#Z?_P"0Z .JHKE?MWCC_H7O#7_@^G_^0Z/MWCC_
M *%[PU_X/I__ )#H ZJBN5^W>./^A>\-?^#Z?_Y#H^W>./\ H7O#7_@^G_\
MD.@#JJY73O\ DJ?B'_L"Z;_Z/OJ/MWCC_H7O#7_@^G_^0ZS?"DNJS?$CQ&VN
M6=E9W/\ 9.FA4L[M[E"GG7N#N:*,@YSQMZ '/.  =Y1110 4444 %%%% %#4
MM)T[5/+_ +3T^TO/+SY?VB%9-N>N-P.,X%+>Z5I]]-!+?6%I<RP',3S0JYC_
M -TD<=!TJ]10!1CTK3XM1>_CL;5;Z08>Y6%1*WL6QGL/RJ]110!RNF_\E3\0
M_P#8%TS_ -'W]=57*Z;_ ,E3\0_]@73/_1]_754 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 5RNG?\E3\0_\ 8%TW_P!'WU=57*Z=_P E3\0_]@73?_1]
M]0!U5%%% !1110 4444 %%%% !1110!RNF_\E3\0_P#8%TS_ -'W]=57*Z;_
M ,E3\0_]@73/_1]_754 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5RNG?
M\E3\0_\ 8%TW_P!'WU=57*Z=_P E3\0_]@73?_1]]0!U5%%% !1110 4444
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M08Q/M#!6'D<':RM@]F![B@#L:*Y7_A/-(_Y\_$G_ (3FH_\ QBC_ (3S2/\
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CLQZ/M/REAT;'&,@XQ6K10 4444 %%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>image00002.jpg
<TEXT>
begin 644 image00002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" %^ C<# 2(  A$! Q$!_\0
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M /!I!_\ %4?\+'\$?]#EX;_\&D'_ ,50!U5%<K_PL?P1_P!#EX;_ /!I!_\
M%4?\+'\$?]#EX;_\&D'_ ,50!U5%<K_PL?P1_P!#EX;_ /!I!_\ %4?\+'\$
M?]#EX;_\&D'_ ,50!U5%<K_PL?P1_P!#EX;_ /!I!_\ %4?\+'\$?]#EX;_\
M&D'_ ,50!U5%<K_PL?P1_P!#EX;_ /!I!_\ %4?\+'\$?]#EX;_\&D'_ ,50
M!U5%<K_PL?P1_P!#EX;_ /!I!_\ %4?\+'\$?]#EX;_\&D'_ ,50!U5%<K_P
ML?P1_P!#EX;_ /!I!_\ %4?\+'\$?]#EX;_\&D'_ ,50!U5%<K_PL?P1_P!#
MEX;_ /!I!_\ %4?\+'\$?]#EX;_\&D'_ ,50!U5%<K_PL?P1_P!#EX;_ /!I
M!_\ %4?\+'\$?]#EX;_\&D'_ ,50!U5%<K_PL?P1_P!#EX;_ /!I!_\ %4?\
M+'\$?]#EX;_\&D'_ ,50!U5%<K_PL?P1_P!#EX;_ /!I!_\ %4?\+'\$?]#E
MX;_\&D'_ ,50!U5%<K_PL?P1_P!#EX;_ /!I!_\ %4?\+'\$?]#EX;_\&D'_
M ,50!U5%<K_PL?P1_P!#EX;_ /!I!_\ %4?\+'\$?]#EX;_\&D'_ ,50!U5%
M<K_PL?P1_P!#EX;_ /!I!_\ %4?\+'\$?]#EX;_\&D'_ ,50!U5%<K_PL?P1
M_P!#EX;_ /!I!_\ %4?\+'\$?]#EX;_\&D'_ ,50!U5%<K_PL?P1_P!#EX;_
M /!I!_\ %4?\+'\$?]#EX;_\&D'_ ,50!U5%<K_PL?P1_P!#EX;_ /!I!_\
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M/AK_ ,$,_P#\F4?8?''_ $,/AK_P0S__ "90!U5%<K]A\<?]##X:_P#!#/\
M_)E'V'QQ_P!##X:_\$,__P F4 =517*_8?''_0P^&O\ P0S_ /R91]A\<?\
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M('<4F1ZB@!:*,@=Q29'J* %HHR!W%)D>HH 6BC('<4F1ZB@!:*,@=Q29'J*
M%HHR!W%)D>HH 6BC('<4F1ZB@!:*,@=Q29'J* %HHR!W%)D>HH 6BC('<4F1
MZB@!:*,@=Q29'J* %HHR!W%)D>HH 6BC('<4F1ZB@!:*,@=Q29'J* %HHR!W
M%)D>HH 6BC(]11D>HH **,@=2*,@=Q0 449 [BDR/44 +11D#N*3(]10 M%&
M0.XI,CU% "T49 [BDR/44 +11D#N*3(]10 M122)%&SR,%11EF8X 'K4A('4
MBN8\4&;4[VVT2"(M$[)/>2-P@A#'Y<^K%<#Z?E45S.Q,WRK0UM6U6WTW29-1
MDW2VZ!2#$ Q8$@#'//45F:);)J^E:C=W"-&NK%^-FQQ%M\M/7JHW?\"K-T4I
M_:%AX>N7,TVE;[AG9>"!\L7_ ([(#[$"NRC1(8U2-51%&%4#  ]JN25-66_Z
M&<;U'=_TSEO ]DLVCPS7<2928-$,YVM'&L.?K\C'\1WKK:JV%K%96_E0GY/,
M>3D]V8L?U-6LCN143ES2;+IPY8I"T=J3([D4$CU%26>;>"9)&^(.M1%B8D:X
M8+V!,J9_'Y1^5>E5QG@O3?(UKQ%>RADE:]DA567&%SOS^.X'\O6NRR!W%;8B
M2E/0PP\7&&HM<KIW_)4_$/\ V!=-_P#1]]74Y'<BN6TW_DJ?B#_L"Z;_ .C[
MZL3<ZJBBB@ HHHH *Y76=!EU#6XKB+3M+MS'-%+_ &F'/VO:A!*A?+'!QL^_
MC:>AZ5U5% ',RQ:K/J$6K6%I;"54EM3;W<[1;H]X*R9",03MSM(Z-UXJC;^'
MM7TZ&>*PDLIVO;989Y9W:,Q.-V710K;A\Y^4E>G4YX[2B@#C=$\.:CIMIIND
M%[4Z5I\_G)<"1C-*H)*J4VA5Y(R0QZ=!GCK+B%9[>6%RX212C%'9& (QPRD$
M'W!!':IJ* /)&\#6]U\0]7M+/6_$5BD&EV,I>/59I9)"\MV,,\K.V!Y? S@;
MFXYK>N/AO"_E?9_$OBNWVH%?&KRR>8P_B.\M@GT7 ]JTM._Y*GXA_P"P-IG_
M */OZZJH<$;QQ-2*23V."N/AO$_E>1XE\5P;5"OC5Y9/,8?Q'>6P3Z+@>U%Q
M\-XG\K[/XE\5P;5"OC5I9/,(_B.\M@GT7 ]J[VBCD0+%55:SV."N/AO$_E>1
MXE\5P;5"OC5Y9/,8?Q'>6P3Z+@>U%Q\-XG\K[/XE\5P;5"OC5I9/,(_B.\M@
MGT7 ]J[VBCD0+%55:SV."N/AO$_E>1XE\5P;5"OC5Y9/,8?Q'>6P3Z+@>U%Q
M\-XG\K[/XE\5P;5"OC5I9/,(_B.\M@GT7 ]J[VBCD0+%55:SV."N/AO$_E>1
MXE\5P;5"OC5Y9/,8?Q'>6P3Z+@>U%Q\-XG\K[/XE\5P;5"OC5I9/,(_B.\M@
MGT7 ]J[VBCD0+%55:SV."N/AO$_E>1XE\5P;5"OC5Y9/,8?Q'>6P3Z+@>U%Q
M\-XG\K[/XE\5P;5"OC5I9/,(_B.\M@GT7 ]J[VBCD0+%55:SV."N/AO$_E>1
MXE\5P;5"OC5Y9/,8?Q'>6P3Z+@>U%Q\-XG\K[/XE\5P;5"OC5I9/,(_B.\M@
MGT7 ]J[VBCD0+%55:SV."N/AO$_E>1XE\5P;5"OC5Y9/,8?Q'>6P3Z+@>U%Q
M\-XG\K[/XE\5P;5"OC5I9/,(_B.\M@GT7 ]J[VBCD0+%55:SV."N/AO$_E>1
MXE\5P;5"OC5Y9/,8?Q'>6P3Z+@>U%Q\-XG\K[/XE\5P;5"OC5I9/,(_B.\M@
MGT7 ]J[VBCD0+%55:SV."N/AO$_E>1XE\5P;5"OC5Y9/,8?Q'>6P3Z+@>U%Q
M\-XG\K[/XE\5P;5"OC5I9/,(_B.\M@GT7 ]J[VBCD0+%55:SV."N/AO$_E>1
MXE\5P;5"OC5Y9/,8?Q'>6P3Z+@>U%Q\-XG\K[/XE\5P;5"OC5I9/,(_B.\M@
MGT7 ]J[VBCD0+%55:SV."N/AO$_E>1XE\5P;5"OC5Y9/,8?Q'>6P3Z+@>U%Q
M\-XG\K[/XE\5P;5"OC5I9/,(_B.\M@GT7 ]J[VBCD0+%55:SV."N/AO$_E>1
MXE\5P;5"OC5Y9/,8?Q'>6P3Z+@>U%Q\-XG\K[/XE\5P;5"OC5I9/,(_B.\M@
MGT7 ]J[VBCD0+%55:SV."N/AO$_E>1XE\5P;5"OC5Y9/,8?Q'>6P3Z+@>U%Q
M\-XG\K[/XE\5P;5"OC5I9/,(_B.\M@GT7 ]J[VBCD0+%55:SV."N/AO$_E>1
MXE\5P;5"OC5Y9/,8?Q'>6P3Z+@>U%Q\-XG\K[/XE\5P;5"OC5I9/,(_B.\M@
M^RX'M7>T4<B!8JJK6>QP5Q\-XG\KR/$OBN#:H5\:O+)YC#^([RV"?1<#VHN/
MAO$_E?9_$OBN#:H5\:M+)YA'\1WEL'V7 ]J[VBCD0+%55:SV."N/AO$_E>1X
ME\5P;5"OC5Y9/,8?Q'>6P3Z+@>U%Q\-XG\K[/XE\5P;5"OC5I9/,(_B.\M@^
MRX'M7>T4<B!8JJK6>QP5Q\-XG\KR/$OBN#:H5\:O+)YC#^([RV"?1<#VHN/A
MO$_E?9_$OBN#:H5\:M+)YA'\1WEL'V7 ]J[VBCD0+%55:SV."N/AO%)Y7V?Q
M-XK@VJ%?&K2R>81_$=Y;!/HN![47'PXB?ROL_B7Q7;[5"N1J\LGF$?Q'>6P3
MZ+@>U=[7-:YXH72[R:,V4TMO!'NEN!PB/C*ITY)RO_?55&CSNR1+QDZ:3;V,
M>X^'$3^7Y'B;Q7!M0*^-7ED\QO[QWEL$^BX'M1<?#>)Q%Y'B;Q7!M4*^-7ED
M\PC^([RV#[+@>U6O">I75]JWVV97^RZE S1[F!$;12LH0#_=()]3G\.P9@@R
MQ !(&3ZDX%.I1479BI8VI))I['"W'PWB?RO(\2^*X-JA7QJ\LGF,/XCO+8)]
M%P/:BX^&\3^5]G\2^*X-JA7QJTLGF$?Q'>6P?9<#VKO:*CD1:Q556L]C@KCX
M;Q/Y7D>)?%<&U0KXU>63S&'\1WEL$^BX'M1<?#>)_*^S^)?%<&U0KXU:63S"
M/XCO+8/LN![5WM%'(@6*JJUGL<%<?#>)_*\CQ+XK@VJ%?&KRR>8P_B.\M@GT
M7 ]J+CX;Q/Y7V?Q+XK@VJ%?&K2R>81_$=Y;!]EP/:N]HHY$"Q556L]C@KCX;
MQ/Y7D>)?%<&U0KXU>63S&'\1WEL$^BX'M1<?#>)_*^S^)?%<&U0KXU:63S"/
MXCO+8/LN![5WM%'(@6*JJUGL<%<?#>)_*\CQ+XK@VJ%?&KRR>8P_B.\M@GT7
M ]J+CX;Q2>5]G\2^*X-JA7QJTLGF$?Q'>6P?9<#VKO:,T<B!8JJK6>QYWJW@
M&WM[,SQ>)/%D7E1@,J:O*YF<=/\ 6%@&)XPN!D]*KZ7\/OMVDV%V_B3Q';W,
MMNC2M!>;"^1D%N"2>>I/J>];T&GZCK%X]W-J!BLUO686ZC<"(9 %'/(R4<GG
MKMKKJTE",5RKKN9PQ55M.^VQY]<?#&U:=)K?Q!XEMYQ&(WE346+R8[LS DG\
M<#@   "I+CX;Q2>5]G\2^*X-JA7QJ\LGF'^\=Y;!/HN![5WM%0XI[FD<34C:
MSV."N/AO$_E^1XE\5P;5"OC5Y9/,(_B.\M@GT7 ]J+CX;Q/Y7D>)?%<&U0KX
MU:63S"/XCO+8/LN![5WM%+D0+%55:SV."N/AO$_E>1XE\5P;5"OC5Y9/,8?Q
M'>6P3Z+@>U%Q\-XG\K[/XE\5P;5"OC5I9/,(_B.\M@^RX'M7>T4<B!8JJK6>
MQP5S\-X)/+^S>(_$]J0H$C1ZG(QF8?QMOW?-VXP, #& *+CX;Q2>5Y'B7Q7!
MM4*^-7ED\QA_$=Y;!/HN![5WM&:'!/<%BJL;6>QP=S\-XG\K[/XE\5P;5"OC
M5Y9/,/\ >.\M@GT7 ]J/!^DPZ)X^UZR@GO;G_B4Z=(\][=RW,KL9;P?>=C@?
M+G:N "3QS7>5RFG_ /)4O$'_ &!M-_\ 1]]344G=$RK3E'ED]$=91115&044
M44 %%%% !1110 4444 <KIO_ "5/Q#_V!=,_]'W]=57*Z;_R5/Q#_P!@73/_
M $??UU5 !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 E4]2OX=.MC+.QY(1$49:1CT51W
M)JJ=?TTP3RPW*3^5)Y1CB.YF?LH'<GM_]:L?2M-?4]:M=>N@\D,L;R0QNWRP
MC*B(A<]2I=C[FKC#K(RE/I$+/Q+/!<6C:S#]FMM17?;-Q^[.>$;GNNTY]2?P
MLV.EQZKX=#W#L?[1>&]G#<C/R'8.^W"@5?\ $6BV^N6(MKH8 D5PXZK@\X^H
MR/QK0M8([:WC@A4+%$H1%'8#@54IQM>.C)C"5[2U1RGC2#['I>G6VFJD)GO#
M O7"F99 Q_-B:JR-)K'@G2K.V,OFRQ,KJ>&S$C#.?^NJQ\]>:[&^LXKZ)$F!
M(25)5(ZAE8,/Y?SKB/"L%U;?$#48[K>L4D=Q/"C'HK3 9QVSM_$8K6G).+?5
M:F=2+C*RV>AVNDZA!JEA'=VI)AD+!21C."0?U%7:YGPK-)#J&KZ0T<*16,N^
M/RL@;96:0#'; ('%=+6$X\LK'13ES1N%%9'A?5O[;T>*]VK&SLX**V=N&(&?
M? %;%3*+B[,J+4E=!1112&)TKF=8U"+5+R/0K9K@&XW>?/",>6B[P1N['<FW
MIWK7UG4H=*TZ>[G9 (T8JK.%WL 2%!/<XJMH.C1:;)<W.2;J[(>XP<IORS';
MGH,N?P [YJXVBN9_(RG>3Y5\S%L/$U[)J45O);Q/! 4M[Z1&^:.9I&C& 2/E
M) /T:N@UB5\6MK%(\;7<WE>8F,H K.2/?"$?CFH]3TJ.:TOOLBI#>7!67S?6
M1,%">O *CCZ^M<SX8,C>)E@O4N$F"2:@4DW *TB1#@'L"9E]JTM&7O1TL9WE
M'W9=3L=+L8M.L8K6WW>7&, L<DGN2?4GFK=+16#=]6="5E8****!A1110 44
M44 %%%% !7*Z=_R5/Q!_V!=-_P#1]]755RNG?\E3\0?]@73?_1]]0!U5%%%
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MDD*Q?=M;D#(VC@]3CGJ[B98+>69PY2-2[!$9V( SPJ@DGV )/:L2Q\+VEG/
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MX'M1[X+V&E[^>WX'-WOQ9\(6 B^WW>I6WFKOC,^CWD>]?49B&1]*+WXL^$;
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M_P"1:ZJB@#E?^$7U?_H>_$G_ 'XT_P#^1:/^$7U?_H>_$G_?C3__ )%KJJ*
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M\-_^"N#_ .)H_P"%<>"/^A-\-_\ @K@_^)H ZJBN5_X5QX(_Z$WPW_X*X/\
MXFC_ (5QX(_Z$WPW_P""N#_XF@#JJ*Y7_A7'@C_H3?#?_@K@_P#B:/\ A7'@
MC_H3?#?_ (*X/_B: .JHKE?^%<>"/^A-\-_^"N#_ .)H_P"%<>"/^A-\-_\
M@K@_^)H ZJBN5_X5QX(_Z$WPW_X*X/\ XFC_ (5QX(_Z$WPW_P""N#_XF@#J
MJ*Y7_A7'@C_H3?#?_@K@_P#B:/\ A7'@C_H3?#?_ (*X/_B: .JHKE?^%<>"
M/^A-\-_^"N#_ .)H_P"%<>"/^A-\-_\ @K@_^)H ZJBN5_X5QX(_Z$WPW_X*
MX/\ XFC_ (5QX(_Z$WPW_P""N#_XF@#JJ*Y7_A7'@C_H3?#?_@K@_P#B:/\
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M_A/-(_Y\_$G_ (3FH_\ QB@#JJ*XZ[^(FA6=K-=7<7B""VA1I)99?#VH*D:
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MFD,:  CY 0#\QSQVX)-7=-O(]0TZUO(,B*XB69 >NU@"/YT 6J*** "BBB@
MK.TW2H-/O=5NH6D,FI7*W4P<@@.(8XOEXZ;8EZYYS3-<O+RUA4:?;Q2RL&9G
MGD,<,2J,DLP!QV X]3VJ+P[KUIKMFDMN2DWE1R2P,"&BWC(Z@9'49'!P: -F
MBBB@ HHHH *SM-TJ#3[W5;J%I#)J5RMU,'((#B&.+Y>.FV)>N><TNNW4UCHM
M]=VT:RS6\#RHC$@,5!./TJKH6O0ZG(UM(IM]2A7=/;$[MG3Y@W0J<C#=_J"
M ;5%%% !1110 5G0Z7!%KUYJR-)]JNK:&U<$_*$B>5E(&,YS,^>>PI-?U$Z5
MH]S>K ]P85W;%SZXR?11U)YP 3BJNC^(;*^FBM%N5ENVC+>9'"ZPS%?O^4Y&
MUL'T)(_.@#<HHHH **** "BBB@ HHHH H:KJ46G1QEXYII96V1PP)N=R!DX'
M3@ GG _$BN:DU"6V6[\1V5])>::7Q<V4HV&%5 4[ V"L@()*G&[..N*J:Q!J
M%G=6<^J:T(Y3%)<B5HU\NUG3:-J84%HV5G4J<L>""#70:#I]R+R]U'44MHY;
MQ8<PP%F3,><2'<H(<Y QC@(O4C- $MC9+>7%EJ$B2V\4*'[-9O&$\DD8W''?
M;P!Q@$@C/3:HHH **** *>I7T6GVWG3!VRP1$C7<SL3PH'J?R'4X S7-RW=Q
M=7-QK6DWD@>T017&EW7[H +EF#9X5SG*OTP,<CD0^([2^$UM+J&K-%;W%TR;
M45 EH%5WBE5B,[AL7=N)4[F'05>\/VEW?7BZOJ'V,K+:?9P8%<"Y4L&#NK@;
M<<X7YOO'GF@"/0]+L=15-3MDU"TLIYA=BQEVI&\F<B79RR\_-C(!(R1WKK**
M* "BBB@"K?W<-C:27-P2(TQG:"22>  .Y)( 'O7.3W%QJ]\;C2;R>SU"P3G3
MKI"BON/_ "T'.5(& ZYVD$Y/*TSQ597TBO-=W[BPENH;;[)&%VB.1T0/NV[A
M(';<#G QC'>I-!M[S4KZQU&XN+.Y@M4EABO( RO=*Q ^92 H7Y0W!8$@$8'4
M MZ5/!XECL-4%O=6K6DK/$7*C?E"K#@G<G)Y'!*@CBNAIJJJ*%4 *!@ <8IU
M !1110!#=7$5I:S7-PXCAA0R.YZ*H&237,W5T^N7D,5A>7FE7]JK3I;W$)7S
MLX"LR_Q1XW CJ"PZ$"E\86]^;*_NWN]MA#$ ;-45DN(\?O1(2-PR,@;2,=>>
ME0Z59WE]>66Z\MKRSTJY<1WH+"=R%*F,\;6QNPS D$KC&>0 %JG_  E3--)]
MOTYX%>SNO)=#%/\ ,0\:L020"H^9=IYQD$$+UT<:QQJD:A40;54= !2HH1<*
M !V &*=0 4444 (S!5)8X ZDUREYJ,7B![6TLKV^TN9F^TV\K1%!<J%."N>&
M&2K%3S@<C!S5SQ-;ZK+#<3V-_P#9(K>W,D:*BOYT@S\L@8'Y, ="#R>>!6'I
M5G/J$-K8V5S;3:997$$\<KE_.M=N'$(XVOQ\N=P(4X8'/(!=L7.MSWUO-8I:
M:Q;H;6YU&&)&7G'RQN>>5.<'.T]>V>IM8([6VB@@7;%$@1%]% P!3U0(#M
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M9XF52ZW,;L2RX8!3SM)<<>H!<TRZOI?*TKQ0;A=0>4.&M$/DSH!G 8#@#'S
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M#5VBB@ HHHH **** *>HZ;8ZE"L>HV5M=QJ=P2XB60 ^N".M68U6-0J *H&
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KI6GW-[%>7%C:RW<7^KG>%6=/HQ&15ZB@ HHHH **** "BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image00003.jpg
<TEXT>
begin 644 image00003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" $H ;8# 2(  A$! Q$!_\0
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M?VGXI_Z%RP_\&O\ ]JH_M/Q3_P!"Y8?^#7_[50!TM%<U_:?BG_H7+#_P:_\
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MT_%/_0N6'_@U_P#M5 '2T5S7]I^*?^A<L/\ P:__ &JC^T_%/_0N6'_@U_\
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M* #%<SXC'_%6^$O^OBX_])WKIJYGQ)_R-OA+_KXN/_2=Z .F'2BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH YKX:?\B%
MH7_7JM=+7-?#3_D0="_Z]5KI: "BBB@ HHI,T +11FDS0 M<SXD_Y&WPE_U\
M7'_I.]=-7,^)/^1M\)?]?%Q_Z3O0!TU%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110!S7PT_Y$'0O^O5:Z6N:^&G_(@Z%_
MUZK72T %%%% #9CB)R=V #]WK^'O7""V6ZT6<J-1M(C=K*EO+:W$K ;2,, 0
MQS]XX. <5WM% ''W<WVW3M,%Y:W/V:(F.]@MA(QCD\OY5^7YB 3VSSC-8=G;
M:P-/&^#4AK6)1<N2^UH?X #]TMMVXV\Y!KTM5"C@ <YX%+0!A>&(_+6\^S1W
M,5@90;=+@.& VC=@/\P&?7WKG_%UMK;^,_#1M-4LH8FGG\E)+%I#'_H[YW'S
M1N[]AU[UWM<SXD_Y&WPE_P!?%Q_Z3O0!)]A\4_\ 0>TK_P %+_\ Q^C[!XI_
MZ#VE?^"E_P#X_7144 <[]@\4_P#0>TK_ ,%+_P#Q^C[!XI_Z#VE?^"E__C]=
M%10!SOV#Q3_T'M*_\%+_ /Q^C[!XI_Z#VE?^"E__ (_7144 <[]@\4_]![2O
M_!2__P ?H^P>*?\ H/:5_P""E_\ X_7144 <[]@\4_\ 0>TK_P %+_\ Q^C[
M!XI_Z#VE?^"E_P#X_7144 <[]@\4_P#0>TK_ ,%+_P#Q^C[!XI_Z#VE?^"E_
M_C]=%10!SOV#Q3_T'M*_\%+_ /Q^C[!XI_Z#VE?^"E__ (_7144 <[]@\4_]
M![2O_!2__P ?H^P>*?\ H/:5_P""E_\ X_7144 <[]@\4_\ 0>TK_P %+_\
MQ^C[!XI_Z#VE?^"E_P#X_7144 <[]@\4_P#0>TK_ ,%+_P#Q^C[!XI_Z#VE?
M^"E__C]=%10!SOV#Q3_T'M*_\%+_ /Q^C[!XI_Z#VE?^"E__ (_7144 <[]@
M\4_]![2O_!2__P ?H^P>*?\ H/:5_P""E_\ X_7144 <[]@\4_\ 0>TK_P %
M+_\ Q^C[!XI_Z#VE?^"E_P#X_7144 <[]@\4_P#0>TK_ ,%+_P#Q^C[!XI_Z
M#VE?^"E__C]=%10!SOV#Q3_T'M*_\%+_ /Q^C[!XI_Z#VE?^"E__ (_7144
M<[]@\4_]![2O_!2__P ?H^P>*?\ H/:5_P""E_\ X_7144 <[]@\4_\ 0>TK
M_P %+_\ Q^C[!XI_Z#VE?^"E_P#X_7144 <[]@\4_P#0>TK_ ,%+_P#Q^C[!
MXI_Z#VE?^"E__C]=%10!SOV#Q3_T'M*_\%+_ /Q^C[!XI_Z#VE?^"E__ (_7
M144 <[]@\4_]![2O_!2__P ?H^P>*?\ H/:5_P""E_\ X_7144 <[]@\4_\
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M9XQW]*BMO%@G:_']B:Y']D1GS)9D";!QB/GYB>P]*Z2BBS[BYX6^'\3ESXP
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M_KXN/_2=Z .FHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M'E04444B@HHHH **** "BBB@ HHHH YKX:?\B#H7_7JM=+7-?#3_ )$'0O\
MKU6NEH **** $;A360=>M_LHEC@NY6:9H$A6/$C,N2< D<8!/.*V#R#C@USL
M>@7B@R'5 ;I;AKB*46P 0L"&!7/((/J,4 7)=;MTL;6XBBN+C[5_JHHDS(<#
M)X)&,8.>:J1>+-.E7S5%S]F*L4G,?R2,HR4'.=PZ8QU!HCT*Z2VMECO1#/:2
M/Y$OE[\HPPV\'&23D\8QQ52W\&1PV8L1?3&PC+O%&5&Y9&Y+%OXN22!CO0!O
M:7J*:@LN(IX)(FV213J%=3@$="1R#V-<[XHU&RA\8>%EFO+:-H[B?>KRJ"N;
M=\9&>*Z#2M/EL_/DN;DW-S.X:238$' P %YP,"N:\5:/IEQXQ\,/<:=92R37
M$_F-);HQ?%N^,DCGI0!TO]MZ5_T$['_P(3_&C^V]*_Z"=C_X$)_C4'_",Z#_
M - 32_\ P$C_ ,*/^$9T'_H":7_X"1_X4 3_ -MZ5_T$['_P(3_&C^V]*_Z"
M=C_X$)_C4'_",Z#_ - 32_\ P$C_ ,*/^$9T'_H":7_X"1_X4 3_ -MZ5_T$
M['_P(3_&C^V]*_Z"=C_X$)_C4'_",Z#_ - 32_\ P$C_ ,*/^$9T'_H":7_X
M"1_X4 3_ -MZ5_T$['_P(3_&C^V]*_Z"=C_X$)_C4'_",Z#_ - 32_\ P$C_
M ,*/^$9T'_H":7_X"1_X4 3_ -MZ5_T$['_P(3_&C^V]*_Z"=C_X$)_C4'_"
M,Z#_ - 32_\ P$C_ ,*/^$9T'_H":7_X"1_X4 3_ -MZ5_T$['_P(3_&C^V]
M*_Z"=C_X$)_C4'_",Z#_ - 32_\ P$C_ ,*/^$9T'_H":7_X"1_X4 3_ -MZ
M5_T$['_P(3_&C^V]*_Z"=C_X$)_C4'_",Z#_ - 32_\ P$C_ ,*/^$9T'_H"
M:7_X"1_X4 3_ -MZ5_T$['_P(3_&C^V]*_Z"=C_X$)_C4'_",Z#_ - 32_\
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M^@G8_P#@0G^-0?\ ",Z#_P! 32__  $C_P */^$9T'_H":7_ . D?^% $_\
M;>E?]!.Q_P# A/\ &C^V]*_Z"=C_ .!"?XU!_P (SH/_ $!-+_\  2/_  H_
MX1G0?^@)I?\ X"1_X4 3_P!M:3_T$K'_ +_I_C2-K.DLI!U*Q((P1YZ?XU#_
M ,(SH/\ T!-+_P# 2/\ PH_X1G0?^@)I?_@)'_A0!GZ.GA[29)7M-1M 9$"8
M-RA"J&8@#GU8U8T6XT72;/[-;ZK:NFXMF2Y0GGWS5C_A&=!_Z FE_P#@)'_A
M1_PC.@_] 32__ 2/_"J<F]V2H16R)_[;TK_H)V/_ ($)_C1_;>E?]!.Q_P#
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M#H**Y_\ X37PO_T,>C_^!L?^-'_":^%_^ACT?_P-C_QH Z"BN?\ ^$U\+_\
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M_P C;X2_Z^+C_P!)WKIJYGQ)_P C;X2_Z^+C_P!)WH Z:BBB@ HHHH ****
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M_"IO^$PB_P"@+XA_\%LG^%;UE:064316L2Q(TCRE5[L[%F/XL2?QJQ0!S/\
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MLS Y#XQ@8Y [\T 3Z?;1ZW8R2:I9R%9A'F.64/&X7D,F/X2>><$]ZW5 50
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M-(I/[SH!G! ]<#F@"Q:VD.L6?G:E8R#?*LHAN) X!3[I7!QCJ??O6W0!@44
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M(-1@2XO[*42&;[0L5RX<QL!@8 . /0?C6Q110 4444 %%%% !1110 8HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH ,4444 %%%% !1110 4444 %%%% !
M1110 4444 &**** "BBB@ HHHH **** "C%%% !1110 4444 &**** "BBB@
3 HHHH **** "BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Submission<br></strong></div></th>
<th class="th"><div>Oct. 16, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissionLineItems', window );"><strong>Submission [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Central Index Key</a></td>
<td class="text">0000947263<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Registrant Name</a></td>
<td class="text">TORONTO DOMINION BANK<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_RegnFileNb', window );">Registration File Number</a></td>
<td class="text">333-283969<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FormTp', window );">Form Type</a></td>
<td class="text">F-3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissnTp', window );">Submission Type</a></td>
<td class="text">424B2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeExhibitTp', window );">Fee Exhibit Type</a></td>
<td class="text">EX-FILING FEES<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTableNa', window );">Offering Table N/A</a></td>
<td class="text">N/A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OffsetTableNa', window );">Offset Table N/A</a></td>
<td class="text">N/A<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CombinedProspectusTableNa', window );">Combined Prospectus Table N/A</a></td>
<td class="text">N/A<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_CombinedProspectusTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_CombinedProspectusTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeExhibitTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeExhibitTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:feeExhibitTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FormTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FormTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OffsetTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OffsetTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_RegnFileNb">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_RegnFileNb</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissnTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissnTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fees Summary<br></strong></div></th>
<th class="th">
<div>Oct. 16, 2025 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesSummaryLineItems', window );"><strong>Fees Summary [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NrrtvDsclsr', window );">Narrative Disclosure</a></td>
<td class="text"><div style="text-align: center; font-family: Arial; font-size: 12pt;">The maximum aggregate offering price of the securities to which the prospectus relates is <span style="text-decoration-thickness: initial; float: none; display: inline !important;">$1,091,000.00</span>. The prospectus is a final prospectus for the related offering.</div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NrrtvMaxAggtOfferingPric', window );">Narrative - Max Aggregate Offering Price</a></td>
<td class="nump">$ 1,091,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FnlPrspctsFlg', window );">Final Prospectus</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesSummaryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesSummaryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FnlPrspctsFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FnlPrspctsFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NrrtvDsclsr">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NrrtvDsclsr</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NrrtvMaxAggtOfferingPric">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NrrtvMaxAggtOfferingPric</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative100TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>12</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>1</UnitCount>
  <MyReports>
    <Report instance="exfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995210 - Document - Submission</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/submissionTable</Role>
      <ShortName>Submission</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="exfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995215 - Document - Fees Summary</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesSummaryTable</Role>
      <ShortName>Fees Summary</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="EX-FILING FEES" original="exfilingfees.htm">exfilingfees.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="2">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
    <BaseTaxonomy items="10">http://xbrl.sec.gov/ffd/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "exfilingfees.htm": {
   "dts": {
    "inline": {
     "local": [
      "exfilingfees.htm"
     ]
    },
    "schema": {
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/arcrole/deprecated-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd"
     ]
    }
   },
   "keyStandard": 12,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 7,
    "http://xbrl.sec.gov/dei/2025": 1,
    "http://xbrl.sec.gov/ffd/2025": 6
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 107,
   "unitCount": 1,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ffd/2025": 10,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/ffd/role/document/submissionTable",
     "longName": "995210 - Document - Submission",
     "shortName": "Submission",
     "isDefault": "true",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exfilingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exfilingfees.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable",
     "longName": "995215 - Document - Fees Summary",
     "shortName": "Fees Summary",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ffd:NrrtvDsclsr",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exfilingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ffd:NrrtvDsclsr",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exfilingfees.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ffd_AggtRedRpPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtRedRpPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtRedRpPricPrrFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtRedRpPricPrrFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Prior Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, Prior FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtSalesPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtSalesPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Sales Price, Fiscal Year",
        "terseLabel": "Aggregate Sales Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtRedCdts": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtRedCdts",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Redemption Credits",
        "terseLabel": "Redemption Credits"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtSctiesRcvd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Received",
        "terseLabel": "Amount of Securities Received",
        "documentation": "Amount of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_AmtSctiesRegd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtSctiesRegd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Registered",
        "terseLabel": "Amount Registered",
        "documentation": "The amount of securities being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CeasedOprsDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CeasedOprsDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ceased Operations Date",
        "terseLabel": "Ceased Operations Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CfwdFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Form Type",
        "terseLabel": "Carry Forward Form Type",
        "documentation": "The Form Type of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrevslyPdFee": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrevslyPdFee",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Previously Paid Fee",
        "terseLabel": "Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward",
        "documentation": "The fee previously paid in connection with the securities being brought forward from the prior shelf registration statement on which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrrFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Prior Effective Date",
        "terseLabel": "Carry Forward Initial Effective Date",
        "documentation": "The initial effective date of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward File Number",
        "terseLabel": "Carry Forward File Number",
        "documentation": "The EDGAR File Number of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). If the prior registration statement has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CmbndPrspctsItemAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsItemAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Item [Axis]",
        "terseLabel": "Combined Prospectus",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different references to earlier prospectuses on a single fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Line Items]",
        "terseLabel": "Combined Prospectus:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Table]",
        "terseLabel": "Combined Prospectus Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CombinedProspectusTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CombinedProspectusTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Table [N/A]",
        "terseLabel": "Combined Prospectus Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CshPdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CshPdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Paid by Registrant in Transaction",
        "terseLabel": "Cash Consideration Paid",
        "documentation": "Amount of cash consideration paid by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "ffd_CshRcvdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CshRcvdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Received by Registrant in Transaction",
        "terseLabel": "Cash Consideration Received",
        "documentation": "Amount of cash consideration received by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "ffd_FeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Amount",
        "terseLabel": "Amount of Registration Fee",
        "documentation": "Total amount of registration fee (amount due after offsets)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeExhibitTp": {
     "xbrltype": "feeExhibitTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeExhibitTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Exhibit Type",
        "terseLabel": "Fee Exhibit Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_FeeIntrstAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Interest Amount",
        "terseLabel": "Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note",
        "terseLabel": "Fee Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNoteMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeNoteMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note Maximum Aggregate Offering Price",
        "terseLabel": "Fee Note MAOP"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeRate",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Rate",
        "terseLabel": "Fee Rate",
        "documentation": "The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesOthrRuleFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeesOthrRuleFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees, Other Rule [Flag]",
        "terseLabel": "Other Rule",
        "documentation": "Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesSummaryLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeesSummaryLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees Summary [Line Items]",
        "terseLabel": "Fees Summary:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FnlPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FnlPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Final Prospectus [Flag]",
        "terseLabel": "Final Prospectus"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FormTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Form Type",
        "terseLabel": "Form Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_GnlInstrIIhiFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "GnlInstrIIhiFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Instruction II.H,I [Flag]",
        "terseLabel": "General Instruction II.H,I"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrCity": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrCity",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, City",
        "terseLabel": "City"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStatOrCtryCd": {
     "xbrltype": "stateOrCountryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStatOrCtryCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, State or Country Code",
        "terseLabel": "State or Country Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt1": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStrt1",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 1",
        "terseLabel": "Street 1"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt2": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStrt2",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 2",
        "terseLabel": "Street 2"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrZipCd": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrZipCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Zip Code",
        "terseLabel": "Zip Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrNm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Name",
        "terseLabel": "Issuer Name"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_MaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "MaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Aggregate Offering Price",
        "terseLabel": "Maximum Aggregate Offering Price",
        "documentation": "The maximum aggregate offering price for the offering that is being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_MaxOfferingPricPerScty": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "MaxOfferingPricPerScty",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Offering Price per Security",
        "terseLabel": "Proposed Maximum Offering Price per Unit",
        "documentation": "The maximum offering price per share/unit being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetFeeAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NetFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Fee Amount",
        "terseLabel": "Net Fee"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetSalesAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NetSalesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Sales Amount",
        "terseLabel": "Net Sales"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvDsclsr": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvDsclsr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure",
        "terseLabel": "Narrative Disclosure"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvMaxAggtAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Amount",
        "terseLabel": "Narrative - Max Aggregate Offering Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Price",
        "terseLabel": "Narrative - Max Aggregate Offering Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Axis]",
        "terseLabel": "Offering",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different security offerings on a single fee bearing submission."
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Line Items]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Note",
        "terseLabel": "Offering Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Title",
        "terseLabel": "Security Class Title",
        "documentation": "The title of the class of securities being registered (for each class being registered)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Type",
        "terseLabel": "Security Type",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Table]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Table [N/A]",
        "terseLabel": "Offering Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OffsetAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset [Axis]",
        "terseLabel": "Offset",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different offsets as applied to a fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetClmInitlFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmInitlFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claim Initial Filing Date",
        "terseLabel": "Initial Filing Date",
        "documentation": "The initial filing date of the earlier registration statement with which the earlier (offsetting) fee was paid for a claimed offset. If the offset fee was paid with an amendment, do not provide the amendment date under this element; instead, provide the date of the initial filing (i.e. the \"parent\" filing) ."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Amount",
        "terseLabel": "Fee Offset Claimed",
        "documentation": "The amount of offsetting fees being claimed."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdInd": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmdInd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Indicator",
        "terseLabel": "Offset Claimed"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetExpltnForClmdAmt": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetExpltnForClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Explanation for Claimed Amount",
        "terseLabel": "Explanation for Claimed Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetLineItems",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset:",
        "label": "Offset [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Note",
        "terseLabel": "Offset Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetPrrFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Fee Amount",
        "terseLabel": "Fee Paid with Fee Offset Source",
        "documentation": "The fee previously paid from which an offset is being derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior File Number",
        "terseLabel": "File Number",
        "documentation": "The EDGAR File Number of the earlier registration statement with which the earlier (offsetting) fee was paid. If the offset filing for the offset has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFilerNm": {
     "xbrltype": "filerNameItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFilerNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Filer Name",
        "terseLabel": "Registrant or Filer Name",
        "documentation": "The name of the registrant that filed the earlier registration statement with which the earlier (offsetting) fee was paid."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Form Type",
        "terseLabel": "Form or Filing Type",
        "documentation": "The Form Type of the offset filing."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrNbOfUnsoldScties": {
     "xbrltype": "nonNegativeIntegerItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrNbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Number of Securities",
        "terseLabel": "Unsold Securities Associated with Fee Offset Claimed",
        "documentation": "The number of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Title",
        "terseLabel": "Security Title Associated with Fee Offset Claimed",
        "documentation": "The title of the class of securities from which offset fees were derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Type",
        "terseLabel": "Security Type Associated with Fee Offset Claimed",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrUnsoldOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrUnsoldOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Offering Amount",
        "terseLabel": "Unsold Aggregate Offering Amount Associated with Fee Offset Claimed",
        "documentation": "The aggregate offering amount of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetSrcFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetSrcFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Source Filing Date",
        "terseLabel": "Filing Date",
        "documentation": "The filing date of the earlier registration statement with which the earlier (offsetting) fee was paid in an offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset Payment:",
        "label": "Offset [Table]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Table [N/A]",
        "terseLabel": "Offset Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_PrevslyPdFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "PrevslyPdFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Previously Paid [Flag]",
        "terseLabel": "Fee Previously Paid"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RegnFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "RegnFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registration File Number",
        "terseLabel": "Registration File Number"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RptgFsclYrEndDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "RptgFsclYrEndDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reporting Fiscal Year End Date",
        "terseLabel": "Reporting FY End Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule011Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 0-11 [Flag]",
        "terseLabel": "Rule 0-11"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011a2OffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule011a2OffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 0-11(a)(2) Offset",
        "label": "Rule 0-11(a)(2) Offset [Flag]"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule415a6Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule415a6Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 415(a)(6) [Flag]",
        "terseLabel": "Rule 415(a)(6)",
        "documentation": "Checkbox indicating whether filer is claiming a 415(a)(6) carryforward."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_Rule429AggtOfferingAmt": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429AggtOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Aggregate Offering Amount",
        "terseLabel": "Maximum Aggregate Offering Price of Securities Previously Registered",
        "documentation": "The maximum aggregate offering amount of unsold securities registered on the prior registration statement that are carried forward under Rule 429. Only applicable if 457(o) was used in the fee calculation for the prior registration statement."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429CmbndPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429CmbndPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Combined Prospectus [Flag]",
        "terseLabel": "Rule 429",
        "documentation": "Checkbox indicating whether filer is using a combined prospectus under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429EarlierFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier File Number",
        "terseLabel": "File Number",
        "documentation": "The Securities Act File Number of the earlier effective registration statement(s) from which securities may be offered and sold using the combined prospectus pursuant to Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429EarlierFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier Form Type",
        "terseLabel": "Form Type",
        "documentation": "The Form Type of the earlier registration statement from which unsold securities are carried forward under Rule 429. This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429InitlFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429InitlFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Initial Effective Date",
        "terseLabel": "Initial Effective Date",
        "documentation": "The filing date of the earlier registration statement from which unsold securities are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429NbOfUnsoldScties": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429NbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Number Of Unsold Securities",
        "terseLabel": "Amount of Securities Previously Registered",
        "documentation": "The number of securities registered on the prior registration statement that are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429PrspctsNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429PrspctsNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Prospectus Note",
        "terseLabel": "Combined Prospectus Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429SctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Title",
        "terseLabel": "Security Class Title"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429SctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Type",
        "terseLabel": "Security Type"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule457aFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457aFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(a) [Flag]",
        "terseLabel": "Rule 457(a)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(a) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "ffd_Rule457bOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457bOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(b) Offset [Flag]",
        "terseLabel": "Rule 457(b) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(b) or 0-11(a)(2)."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "ffd_Rule457fFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457fFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(f) [Flag]",
        "terseLabel": "Rule 457(f)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_Rule457oFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457oFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(o) [Flag]",
        "terseLabel": "Rule 457(o)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(o) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "ffd_Rule457pOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457pOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(p) Offset [Flag]",
        "terseLabel": "Rule 457(p) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(p)."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "ffd_Rule457rFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457rFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(r) [Flag]",
        "terseLabel": "Rule 457(r)"
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "ffd_Rule457sFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457sFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(s) Flag",
        "terseLabel": "Rule 457(s)"
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "ffd_Rule457uFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457uFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(u) [Flag]",
        "terseLabel": "Rule 457(u)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(u) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "ffd_Scties424iAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Axis]",
        "terseLabel": "Securities, 424I"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Line Items]",
        "terseLabel": "Securities, 424I:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Table]",
        "terseLabel": "Securities, 424I Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Securities424iTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Securities424iNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities 424I [N/A]",
        "terseLabel": "Securities 424I N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "SubmissionLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission [Line Items]",
        "terseLabel": "Items"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissnTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "SubmissnTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission Type",
        "terseLabel": "Submission Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TermntnCmpltnWdrwl": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TermntnCmpltnWdrwl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Termination / Completion / Withdrawal Statement",
        "terseLabel": "Termination / Withdrawal Statement"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TtlFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee Amount",
        "terseLabel": "Total Fee Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlFeeAndIntrstAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlFeeAndIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee and Interest Amount",
        "terseLabel": "Total Fee and Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offering Amount",
        "terseLabel": "Total Offering"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOffsetAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlOffsetAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offset Amount",
        "terseLabel": "Total Offset Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlPrevslyPdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlPrevslyPdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Previously Paid Amount",
        "terseLabel": "Previously Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlTxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlTxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Transaction Valuation",
        "terseLabel": "Total Transaction Valuation"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transaction Valuation",
        "terseLabel": "Transaction Valuation"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_ValSctiesRcvd": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "ValSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received",
        "terseLabel": "Value of Securities Received",
        "documentation": "Value of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_ValSctiesRcvdPerShr": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "ValSctiesRcvdPerShr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received, Per Share",
        "terseLabel": "Value of Securities Received, Per Share",
        "documentation": "Value per share of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form). This is included in the explanation of 457(f) fee calculation."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "415",
   "Subsection": "a"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "429"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "f"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "o"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "p"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "r"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "s"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "u"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Subsection": "f",
   "Section": "457"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001140361-25-038552-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001140361-25-038552-xbrl.zip
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D9FEL:6YG9F5E<RYH=&U02P4&      $  0 ^    F@@

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>exfilingfees_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:ffd="http://xbrl.sec.gov/ffd/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef
      xlink:href="https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd"
      xlink:type="simple"/>
    <context id="c0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000947263</identifier>
        </entity>
        <period>
            <startDate>2025-10-16</startDate>
            <endDate>2025-10-16</endDate>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <ffd:FormTp contextRef="c0" id="ixv-32">F-3</ffd:FormTp>
    <dei:EntityRegistrantName contextRef="c0" id="ixv-33">TORONTO DOMINION BANK</dei:EntityRegistrantName>
    <ffd:NrrtvDsclsr contextRef="c0" id="ixv-26">&lt;div style="text-align: center; font-family: Arial; font-size: 12pt;"&gt;The maximum aggregate offering price of the securities to which the prospectus relates is &lt;span style="text-decoration-thickness: initial; float: none; display: inline !important;"&gt;$1,091,000.00&lt;/span&gt;. The prospectus is a final prospectus for the related offering.&lt;/div&gt;</ffd:NrrtvDsclsr>
    <ffd:NrrtvMaxAggtOfferingPric contextRef="c0" decimals="2" id="ixv-34" unitRef="usd">1091000</ffd:NrrtvMaxAggtOfferingPric>
    <ffd:FnlPrspctsFlg contextRef="c0" id="ixv-35">true</ffd:FnlPrspctsFlg>
    <ffd:CombinedProspectusTableNa contextRef="c0" id="ixv-38">N/A</ffd:CombinedProspectusTableNa>
    <dei:EntityCentralIndexKey contextRef="c0" id="ixv-39">0000947263</dei:EntityCentralIndexKey>
    <ffd:FeeExhibitTp contextRef="c0" id="ixv-40">EX-FILING FEES</ffd:FeeExhibitTp>
    <ffd:OfferingTableNa contextRef="c0" id="ixv-41">N/A</ffd:OfferingTableNa>
    <ffd:OffsetTableNa contextRef="c0" id="ixv-42">N/A</ffd:OffsetTableNa>
    <ffd:RegnFileNb contextRef="c0" id="ixv-43">333-283969</ffd:RegnFileNb>
    <ffd:SubmissnTp contextRef="c0" id="ixv-44">424B2</ffd:SubmissnTp>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
